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ABSTRACT 
African Sleeping Sickness afflicts millions of people in sub-Saharan areas of the continent.  The 
disease causing agent, the unicellular eukaryotic protozoan Trypanosoma brucei, is intensely 
studied, yet no safe cure has been developed and has become a public health issue.  Because 
gene expression control in T. brucei exhibits unique patterns, it is attractive for drug targeting.  
Our lab aims to explore the cellular and molecular role(s) of TbEIF4E-3 (4E-3p) and TbeIF4E-5 
(4E-5p), structurally divergent homologs of eukaryotic translation initiation factor 4E (eIF4E), a 
canonical mRNA 5’ cap binding protein involved in post-translational regulation of gene 
expression. The 4E-3 and 4E-5 proteins are essential in cell cycle in trypanosomes.  We 
hypothesize 4E-3p and 4E-5p to be key regulons, proteins that regulate the translation of distinct 
sets of multiple, functionally related mRNAs required for normal cell cycle.  Evidence from 
immunofluorescence microscopy (IMF) by other labs and our own revealed cytoplasmic 
localization of 4E-3p in mRNP granules.   Tandem co-immunoprecipitation (co-IP) and mass 
spectrometry (MS) revealed 4E-3p association with canonical protein partners found in other 
eukaryotes known to be involved in translation initiation and control such as eIF4G and eIF4A, 
consistent with earlier studies. Significantly, this present work further identified unique 
uncharacterized polypeptides, implying both conserved as well as novel functions.  Additionally, 
RNAseq analysis from co-IPs revealed that 4E-3p also associates with various mRNAs, some of 
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which are involved in the cell cycle, providing evidence towards potential translational 
regulation of cell cycle.  By contrast, 4E-5p appeared more associated with the mitochondria 
from IMF studies, consistent with findings by others. Combined co-IP and MS analysis showed 
association with translational regulators, whereas RNAseq revealed association with mRNAs 
regulating cell division and replication control distinct from those associated with 4E-3p.  These 
findings suggest that both 4E-3p and 4E-5p may act separately to regulate cell cycle, replication, 
and gene expression  in T. brucei in a manner consistent with a proposed Parallel RNA Regulon 
Model.  Among potential drug targets being analyzed are translational regulating proteins, of 
which 4E-3p and 4E-5p are attractive candidates due to their discovered role in normal cell 
cycle. 
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1.0  INTRODUCTION 
Trypanosoma brucei is a pathogenic, unicellular eukaryotic protozoan of the kinetoplast group. 
These specific protozoans maintain only one flagellum and one large mitochondrion containing a 
kinetoplast, and are closely related to Trypanosoma cruzi and the Leishmania species.  The three 
protozoans, called “TriTryps,” are the cause of millions of infections in humans across the world 
(WHO 2008), mostly in tropical and sub-tropical areas.  T. brucei, specifically, is the pathogen 
responsible for the Human African Trypanosomiasis (HAT), or more commonly called “African 
Sleeping Sickness” [3][4]. 
Infection occurs through the bite of a tsetse fly, where the parasite exists in the procyclic 
form (PF) in the fly’s midgut.  Upon entering the blood stream, the parasite enters the blood form 
(BF) stage and travels to the lymph nodes.  The PF exhibits very few variable surface 
glycoproteins (VSGs), while the BF exhibits dense clusters of VSGs (Figure 1).  The increase in 
VSGs assist in host immune system evasion, and have recently become attractive targets for 
control of infection[5][6].  From here the proliferating parasites traverses the blood-brain barrier, 
eventually causing death [5][6].  HAT has been known to cause symptoms ranging from 
headaches and joint pain, common to the Early Stage of infection, to more severe neurological 
disorders once the parasite crosses the blood-brain barrier, during the late stage of infection. 
Once this occurs, seizures often ensue, followed by coma and eventually death if not treated.  
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The late stage of infection is characterized by disruptions in sleep patterns.  The symptoms do 
not always show up immediately, often not presenting themselves for months or even years after 
infection, hindering attempts to treat the disease before the onset of the late stage of infection [7]. 
HAT is endemic in low-income regions of sub-Saharan Africa, making the disease a 
neglected tropical disease [8-10].  The drugs developed to target HAT can be severe, in the case  
 
 
Figure 1. Life Cycle of T. brucei.   
 
Procyclic forms of the parasite exist in the midgut of the tsetse fly, becoming the blood form upon entering the 
bloodstream of the host.  This blood form stage exhibits clusters of variable surface glycoproteins (VSGs) that allow 
for immune system evasion.  Adapted from http://www.cdc.gov/dpdx/trypanosomiasisAfrican/index.html 
 
of melarsoprol, which exhibits acute toxicity due to it being an arsenic derivative, or requiring 
multiple doses, such as eflornithine, which is less severe than melarsoprol, exhibiting reversible 
 3 
toxic effects but remaining harder to administer in rural Africa [11-15].  While these drugs were 
developed in the 20th century, with melarsoprol being discovered in 1949 and eflornithine being 
registered for use on patients with HAT in 1990, there have been only minor steps forward in 
new drug development, and now strains of trypanosomes are arising with drug resistance [11-
13].  A newer drug, DB289, which is a novel aromatic diamidine, was in the final clinical stages, 
and, while purportedly safer, there is still a 10 day treatment required, a very difficult 
requirement in rural Africa.  The latest data on DB289 now suggest severe liver toxicity and 
delayed renal toxicity, and research has since been discontinued.  However, the aza analogs 
DB820 and DB829 are currently being investigated as well [16-18].   
 
With the availability of the Tri-Tryps genome and proteome databases (tritrypsdb.org), 
the opportunity to find genes for new and better drug targets is wide-open.  Proteins that act as 
translational regulators are now high on the list of possible drug targets due to their essential role 
in the normal cell cycle and their unique structural features, as described below. 
1.1 EUKARYOTIC INITIATION FACTOR 4E (EIF4E) 
Eukaryotes possess cap-binding proteins that bind to the 5’ end of mRNAs and help initiate 
translation [19]. They are broadly referred to as eukaryotic initiation factor 4E (eIF4E) [20].  
Because of the lack of transcriptional regulation in trypanosomes, the T. brucei eIF4E’s 
(TbeIF4E's) are expected to play a more prominent role in controlling gene expression by 
regulating which mRNAs are translated at which time [1][21].  Indeed this 5’ cap-binding 
protein has multiple homologs present in other eukaryotes, potentially allowing for a wide  
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Figure 2. eIf4E-mediated cap-dependent translation 
initiation.  
 
eIF4E is indicated by a red arrow.  (Adapted by permission 
from Macmillan Publishers Ltd: Nature Reviews Molecular 
Cell Biology (Ref. 23), copyright (2004). 
 
 
variety of functions through association with other distinct protein factors, ranging from 
transporting the processed mRNAs from the nucleus to mRNA localization, stability and 
translation initiation [22].  In the initiation of translation, the eIF4E (4E) homologs are a key 
component in the eIF4F (4F) complex that recruits the small ribosomal subunit to the capped 
mRNA (Figure 2) [23].  Aside from 4E, the 4F complex in eukaryotes consists of two other key 
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proteins, eIF4G (4G) and eIF4A (4A).  4G assists in the binding of other proteins to the 4F 
complex, such as the mRNA 3’ polyA binding protein (PABP), 4A and other initiation factors 
(e.g. eIF3) that are bound directly to the 40S ribosomal subunit to initiate translation [24].  The 
most fundamental interaction of 4G is the direct binding of 4E, which is a critical step to allow 
4E to initiate translation [25][26].  4A is a RNA helicase that unwinds the secondary structures 
of the mRNA to permit 40S ribosomal subunit binding [24][27][28]. 
 
Depending on cell growth, 4E exists in a phosphorylated state [29][30].   When the cell is 
undergoing active growth and proliferation the amount of phosphorylated 4Es are low in 
proportion to levels of 4E while the cell is not undergoing active growth. Due to this 
phosphorylation in the cytoplasm by the target of rapamycin (TOR), related to the 
phosphatidylinositol 3-kinase (PI3K) family, 4E has been proposed to be a rate limiting step in 
translation initiation and cellular proliferation [19][30]. In mouse models, an overabundance of 
4E causes excessive growth and division of cells, leading to the generation of tumors [31][32], 
while HeLa cells engineered to produce less 4E than controls were shown to have a division rate 
four to seven times slower [33].  Because of this, 4E plays a key role in translation regulation and 
is also designated as an oncogene. As such, 4E activities including cap-binding, localization, and 
4F assembly are subject to the effects of many different stimuli and growth factors.  From yeast 
to man, there are key activation pathways associated with both growth and stress signals, such as 
the mTOR and p38 pathways, involving phosphorylation of 4E and/ or other 4F components, 
leading to an increase in cell proliferation or even apoptosis [34]. 
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1.2 T. BRUCEI EIF4E-3 (TBEIF4E-3) AND EIF4E-5 (TBEIF4E-5) PROTEINS 
Similar to other eukaryotes, two of T. brucei's eIF4E orthologs, designated TbeIF4E-3 (4E-3) 
and TbeIF4E-5 (4E-5), were shown through RNAi knockdowns to be critical to cell viability [1] 
and proper cell division in trypanosomes, causing cell deformations and producing multiple or no 
kinetoplasts and nuclei [S.Tarun and J. Rocco, data not shown][2].  Partial knockdown of 4E-3 
caused rapid loss of general translation based on 35S-methionine incorporation, as well as rapid 
reduction of mRNA levels of selected cell-cycle related genes, suggesting a role for 4E-3 protein 
(4E-3p) in mRNA stability related to cell cycle process [2].  Consistent with a possible direct 
role in translation, trypanosome homologs of 4G and 4A proteins were shown to co-purify with 
exogenously expressed hemagglutinin (HA)-tagged 4E-3p [1].   4E-3p shows homology with 
yeast 4Ep via conserved motifs in the 5’ cap binding region. However, it is highly unusual  
 
Figure 3. Comparison of 4E homology of cap-binding domains in the five orthologs in trypanosomes with 
human and yeast forms.   
 
The conserved cap-binding cores are depicted in blue, with the species-specific polypeptide differences depicted in 
red.  The T. brucei eIF4Es (TbeIF4Es) show homology with yeast eIF4Es based on these conserved cores.  
TbeIF4E-3 exhibits a long N-terminal region conserved amonst the TriTryps species and suggest possible new 
binding interactions.   
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because of a long N-terminal extension, making it two times larger than typical 4Es (Figure 3). 
This unique feature is also conserved in related T. cruzi and Leishmania species [1][21][35], 
suggesting potentially new binding interactions, function or regulation for this 4E homolog. 
These properties could make 4E-3p a potential drug target against the parasite. 
 
The protein TbeIF4E-5 (4E-5p) is another 4E homolog based on its conserved cap-
binding domain (Figure 3).  By RNAi knockdown, 4E-5p was also shown to be growth essential 
affecting cell morphology and cell cycle [2].  Intriguingly, it was identified as part of the T. 
brucei mitochondrial proteome by mass spectrometry (MS) analysis, suggesting an unusual 
possibility that a 4E-like protein might associate or reside in/on the mitochondrion of the parasite 
[36]. This has not been observed in other eukaryotes.  If verified, this would have profound 
implication in the evolution of 4E function and eukaryotic translation since the mitochondrion is 
thought to be a derivative of ancient prokaryotes [37]. 
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2.0  STATEMENT OF THE PROBLEM 
The 4E-3p interaction with translational proteins has been analyzed in other studies using in vitro 
hemagglutinin (HA) tagged, exogenously expressed proteins in T. brucei to determine its 
potential biochemical function, whereas 4E-5p remains to be examined in detail [1][21].  
Although a role in translation is becoming evident for 4E-3p, we still do not know the precise 
biochemical interactions and functions of 4E-3p and 4E-5p in vivo, much less their fundamental 
connections to normal cell cycle. 
2.1 HYPOTHESIS 
Based on functions of 4E and the existence of 4E in other eukaryotic systems, we hypothesize 
that: (1) 4E-3p binds directly to target cytoplasmic mRNAs involved in the cell cycle and 
interacts with other post transcriptional proteins to regulate their translation and/or mRNA 
stability, and that (2) 4E-5p associates with mitochondria and binds mitochondrial-related 
mRNA to regulate their expression, stability or localization.  These hypotheses propose that 4E-
3p and 4E-5p act on mRNA regulons, perhaps like 4Es in other eukaryotes that act as mRNA 
regulons for coordinated nuclear export or translation of functionally-related mRNAs [38][39]. A 
regulon is defined as multiple mRNAs which are structurally related and/or contribute to the 
same function regulated by an RNA binding protein (RBP) [40]. In our models, 4E-3p and 4E-5p  
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interact with their own unique sets of mRNAs that play key roles in cell cycle and growth 
regulation, either in parallel or in sequence.  In the Parallel Regulon Model, 4E-3p and 4E-5p 
independently act as regulons for unique sets of functionally related mRNA.  In the Sequential 
Regulon Model, 4E-3p and 4E-5p act as regulons for shared mRNAs at distinct stages of a single 
post-transcriptional pathway (Figure 4). 
Figure 4. Regulon Models for 4E-3 and 
4E-5: Sequential vs Parallel .
We hypothesize that TbeIF4E-3 and TbeIF4E-5 
bind to distinct regulons to regulate cell cycle (A) 
independently on separate mRNA regulons that 
share similar functions or (B) in sequence on the 
same mRNA regulons or mRNA regulons in the 
same pathway.  A regulon is a group of 
functionally related mRNA that are regulated by 
an RNA binding protein (RBP). 
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2.2 SPECIFIC AIMS 
The purpose of these studies in general were to further analyze the biochemical functions of 4E-
3p and 4E-5p in trypanosomes, and how their molecular functions impact cell cycle. Thus, the 
specific aims of this project were:  
(1) To determine the intracellular locations of 4E-3p versus 4E-5p using 
immunofluorescence microscopy. 
(2) To develop a coimmunoprecipitation (co-IP) method to capture 4E-3p 
associated mRNAs and polypeptides. 
(3) To determine the associated mRNA and polypeptide identities by RNAseq and 
mass spectrometry (MS) analyses respectively, in order to begin to elucidate their 
biochemical functions (Figure 5).  
 
 
Figure 5. Work flow of experimental plan.   
 
This is a graphical depiction of the aims and the procedures to accomplish them.  Aim 1 focused on the 
determination of the intracellular locations of 4E-3p and 4E-5p using immunofluorescence microscopy.  Aim 2 was 
to develop an optimized co-immunoprecipitation (co-IP) method to capture any proteins or mRNAs associated with 
4E-3p and 4E-5p.  Aim 3 focused on determining the identities of the mRNA and polypeptides via RNAseq and 
mass spectrometry (MS) analysis respectively, which would provide possible functions and relations to 4E-3p and/or 
4E-5p. 
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3.0  MATERIALS AND METHODS 
3.1 CELL CULTURING 
Procyclic forms of the 29.13 cell line of T. brucei were used [41].  The 29.13 transgenic cell 
lines were grown in SDM79 (Gibco) with 10% fetal bovine serum (FBS; GIBCO) treated with 
15ug/mL of G-418 (Fisher) and 25ug/mL of hygromycin (Fisher).  The RNAi transgenic strains 
of 29.13 harbored a pZJM plasmid, which contains tetracycline-inducible T7 promoters and 
gene-specific target sequences against TbeIF4E-3p (4E-3 RNAi), the forward primer being 5'-
GACCTCGAGGTTGGGGATGTTGAGTGCTT-3' and reverse primer being 5'-
GCCAAGCTTTCGACGGTTTTCCTTTCATC-3', and TbeIF4E-5p (4E-5 RNAi), the forward 
primer being 5’-GACCTCGAGGAAGGATCCCTGGTTTGTGA-3' and reverse primer being 5'-
GCAAAGCTTCGCCAAAAATAACGTGAGGT-3' [2][42][43].  These allowed for the 
validation of successful transfection through polymerase chain reaction (PCR) and gel 
electrophoresis using the restriction enzyme Xhol, the sequence underlined and italicized, and to 
incur partial knockdown of the mRNA that encode for the target proteins 4E-3p and 4E-5p 
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Figure 6. Graphical depiction of methodology.   
 
Cell culturing was designed to create RNAi cell lines that would cause a partial knockdown of 4E-3p and 4E-5p.  
From here, immunofluorescence was performed to verify the locations of the target proteins.  Co-
immunoprecipitation was optimized and performed to ensure almost complete pulldown of 4E-3p and 4E-5p using 
affinity purified antibodies (Ab) targeting the proteins.  Half of these samples were sent for mass spectrometry (MS) 
analysis to determine possible proteins interactors and functions of 4E-3p and 4E-5p as possible regulators of 
translation.  The other half was sent for RNAseq to identify overrepresented mRNAs specific for 4E-3p and/4E-5p.  
These mRNAs could possibly share functionality or pathways, making them mRNA regulons.  The mRNA identities 
were verified using TriTryps, with hypothetical unknowns being analyzed for predicting polypeptide composition 
and ran through the BLASTp algorithm for putative function and protein homology.  The identified mRNAs were 
analyzed for conserved motifs in their 3’ UTRs, showing a possible site for 4E-3p and/or 4E-5p interaction.  These 
3’ UTRs were then analyzed via RNAfold for secondary structure similarities and motif location.  Should the motif 
reside on loops and/or bulges, that would assist in 4E-3p and/or 4E-5p direct or indirect interaction. 
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Both the 4E-3 and 4E-5 RNAi lines received the addition of 2.5ug/mL phleomycin 
(Invitrogen) in the cell culture to select for the successfully transformed cells.  The cell cultures 
were kept at 1x106 cells/mL by monitoring their counts with the Automated Cell Counter 
(Invitrogen), maintained every two days with fresh SDM79+10% FBS with the required 
antibiotics.  Inducing the 4E-5 and 4E-3 RNAi lines to cause a partial knockdown of the target 
proteins 4E-5p and 4E-3p required the addition of 1ug/mL tetracycline at a concentration of 
1x106 cells/mL. 
3.2 IMMUNOFLUORESCENCE STAINING 
In collaboration with Joseph Rocco (Pitt Medical Student), approximately 5x107 cells of non-
induced and induced 4E-3 and 4E-5 RNAi procyclic (insect stage) cells were harvested and 
incubated separately in 500nM MitoTracker Red at 37C for 10 minutes to stain the single 
mitochondrion in each cell (Invitrogen). The induced 4E-3 and 4E-5 RNAi were added to show 
the effects of their target protein knockdown.  After spinning the cells down twice at 4,000 RPM 
at 4°C for 10 minutes and washing with medium in between, the cells were then fixed in 4% 
paraformaldehyde (Fisher) for 20 minutes onto separate microscope slides (Fisher) and 
permeabilized with 1% Triton x-100 (Fisher) for 15 minutes and washed three times with 1x 
PBS, finally being resuspended with 10% BSA (SIGMA) in PBS.  The cells were then incubated 
with affinity purified primary antibodies (Ab) for two hours using a 1/200 concentration of 4E-3 
rabbit Ab for the 4E-3 RNAi line and a 1/200 concentration of 4E-5 rabbit Ab for the 4E-5 RNAi 
line.  The cells were then washed three times with 1% BSA.  The customized Abs were designed 
according to the manufacture’s proprietary software (Open Biosystems), with the 4E-3 Ab being 
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raised from an N-terminal peptide from amino acid (a.a.) positions 4-22 
(EAEEFVPKGNRTPGSGGRR) and the 4E-5 Ab being raised from an N terminal peptide from 
a.a. positions 3-23 (EESHALKDPWFVSYIPQLTTE).  The secondary antibody was added, a 
1/400 concentration of fluorescein (FITC; Thermo Fisher) as the secondary goat anti-rabbit 
antibody for the 4E-3 and the 4E-5 strains, incubated for two hours, then washed three times with 
1% BSA in PBS (Figure 7).  The final stain of 300ng/mL DAPI to stain the DNA was applied 
for 10 minutes.  The samples were then viewed with an Olympus Provis AX70 Fluorescence 
Microscope with a standard lens, using the U-PHOTO Universal Photo System through the 
University of Pittsburgh Center for Biologic Imaging. 
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Figure 7. Immunofluorescence methodology.  
 
Graphical depiction of antibody-antibody-protein interaction with 
staining of the mitochondrion and nucleus using MitoTracker Red and 
Dapi, respectively.  The primary antibodies (Abs) were affinity purified 
rabbit Abs raised against 4E-3p or 4E-5p.  The secondary Ab was an anti-
rabbit goat FITC Ab. 
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3.3 CO-IMMUNOPRECIPITATION 
The following co-immunoprecipitation (coIP) protocol was derived from a series of systematic 
optimization studies. Four cultures were prepared of the 4E-3 RNAi cell line, with one culture 
receiving Tetracycline (Tet) to induce the 4E-3 RNAi while the others remained untreated (non-
induced).  Each was harvested at day 2, when complete down-regulation and a loss of 90% of 
target protein occurs in induced cells without growth defects [2], with one of the non-induced 
cultures receiving a constant cycloheximide (CHX) (Fisher) treatment of 100ug/mL throughout 
the rest of the coimmunoprecipitation (co-IP) in order to arrest translation and allow potential 
polyribosome – associated 4E-3 complexes to be captured.  Cell cultures comprised of roughly 
1x108 cells were spun down at 4,000 RPM at 4°C and washed gently so as not to disturb the 
pellet three times.  The pellets were then resuspended in a low stringency (10mM) KCl salt 
solution lysis buffer and subjected to douncing with a glass rod, all the while being kept on ice.  
Each of the samples were lysed using a low stringency salt solution to preserve protein-protein 
interaction.  The samples were then spun at 14,000 RPM at 4°C to separate the target proteins 
and their associated complexes from the rest of the sample.  The resultant total lysate was then 
subjected to incubation with optimized amounts of affinity purified Ab raised against 4E-3p and 
4E-5p (as specificity control), followed by subsequent incubation with magnetic Protein A 
Sepharose beads (Invitrogen), again all performed on ice.  The resultant protein-Ab-bead 
complexes were then placed in a magnetic rack and washed with a high stringency (120mM) 
KCl salt solution to remove any non-specific binding (Figure 8).  This entire process was done 
in triplicate and any subsequent experiments used a pool of the three trials.  The samples were as 
follows: Sample 1 received only the 4E-5 antibody; Sample 2 received only the 4E-3 antibody; 
Sample 3 received the 4E-3 antibody with a constant treatment of CHX (Acros Organics); and 
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Sample 4 received the 4E-3 antibody with Tet treatment.  The amounts of Abs used were 
optimized to allow for quantitative pulldown of the target antigen to near complete depletion 
from the lysate, as assessed by western blot analysis. Samples were also taken at each step to 
verify the efficacy of the Ab pulldown via western blot analysis. 
3.4 MASS SPECTROMETRY 
 
 
 
 
Figure 8. Graphical depiction of anti-4E-3p and anti-4E-5p antibody (Ab) pulldown of target 
protein with magnetic Protein A Sepharose beads.   
 
Samples were taken to verify specificity of the Ab pulldown and ensure the most efficient capture 
of the target proteins and their associated complexes and mRNA. 
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Half of the samples that were prepared using co-IP and confirmed via western blot (Samples 1-3) 
were then subjected to SDS PAGE treatment to purify the total proteins that were pulled down.  
These samples were then run on a Mini-Protean TGX Gel (Bio Rad), and stained using Sypro 
Ruby.  The lanes of the gel were then cut, partitioned into thirds, and sent out for MS Analysis at 
the Biomedical Mass Spectrometry Center at the University of Pittsburgh.  The data obtained 
from Dr. Manimalha Balasubramani at the  MS Center were then analyzed using BLAST 
through NCBI and the TriTryps database to examine the proteins pulled down through coIP and 
to identify candidate 4E-3 and/or 4E-5 protein interactors. 
3.5 RNA ISOLATION FROM IMMUNOPURIFIED COMPLEXES 
The other half of the samples prepared using co-IP and confirmed via Western (Samples 1-4) 
were also subjected to ethanol treatments to precipitate the RNA following the protocol in the 
Qiagen RNA Prep Handbook (Jan. 2006).  In this protocol, the coIP samples were treated with 
proteinase K (Sigma) at a concentration of 0.1ug/mL, then were heated at 42°C.  Sodium acetate 
(Fisher) was then added to each sample at a concentration of 0.3M and a pH of 5.2.  Two 
volumes of phenol chloroform isoamyl alcohol (PCI) (ACROS) were added next, with the 
samples then being spun at 14,000 RPM at 4°C.  The upper aqueous layer was carefully 
extracted, then treated with two volumes of chloroform isoamyl alcohol (ACROS) and spun once 
more at 14,000 RPM at 4°C.  The aqueous layer containing the RNA was removed and was 
treated with glycogen at a concentration of 1ul/sample to assist in RNA precipitation.  Each 
sample received 2.5 volumes of 100% ethanol (Fisher) and were spun at 14,000 RMP at 4°C to 
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pellet the RNA.  The ethanol was poured out and the pelleted RNAs were allowed to dry slightly, 
then were resuspended in RNase free water (Fisher).   
 
The RNA concentrations were determined using a Nanodrop instrument and then sent out 
for analysis to determine mRNA identity and quantity by Rahil Sethi and Dr. James Lyons-
Weiler at the University Bioinformatics Core Facility.  The RNA samples were analyzed using 
both Burrows-Wheeler Aligner (BWA), which is bidirectional and functions well for ungapped 
reads, and Bowtie, which performs well with gapped reads, to ensure full coverage of the 
mRNAs in each sample [44].  It was discovered that each mapper provided different results for 
the mRNAs specific to each sample, with only a few shared results, so the overlap was used to 
reduce the chance of having mRNAs specific to neither sample and to ensure the most accurate 
results.  The TREU927 and Lister 427 reference sequences were used to identify each mRNA, 
again using the overlap to ensure positive identification of the mRNAs present due to each 
approach yielding different results. 
3.6 DISCOVERY OF CONSERVED MOTIFS USING CAGEDA AND TRAWLER 
The data returned were then analyzed using caGEDA (helen.genetics.pitt.edu) to discover the 
overrepresented mRNAs in each sample [45].  The sample comparisons used were the 4E-5 
untreated coIP versus the 4E-3 untreated coIP (4E5v4E3), the 4E-3 untreated coIP versus the 
4E3+CHX (4E3v4E3+CHX), and 4E-3 coIP versus the 4E-3+Tet treated coIP (4E3v4E3+Tet).   
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For each sample comparison, normalizations were performed to ensure only 
overrepresented mRNAs specific for each sample were selected.  Each mRNA was then assigned 
significance based on a mean scaled value that adjusts for a difference in total hits between 
samples, which represents differential expression in relation to the compared sample, and was 
used as a threshold to determine sample-specific mRNAs and eliminate mRNAs shared equally 
between the compared samples.  Biological significance could be determined by taking the mean 
scaled value of a specific mRNA overrepresented in one sample over the mean scaled value of 
the same mRNA that is underrepresented in the compared sample to determine fold-change, 
although values were not shown for the compared underrepresented mRNAs.  Instead, 
proportions of the mean scaled values of sample specific mRNAs were used, allowing for a 
quantitative significance of the mRNAs in each sample.  The threshold was used as a baseline to 
determine the quantitative value of each overrepresented mRNA.  The data generated by 
caGEDA provided an expression grid based on the threshold entered with the value changed to 
ensure only mRNAs with a p-value above 95%, for specificity in the first sample, or below 5%, 
signifying a p-value of 95% in the second sample.  This allowed for a selection of mRNAs 
overrepresented in each sample with the highest statistical significance, and eliminated 
nonspecific mRNAs. 
 
The 4E5v4E3 analysis was normalized to fix varying means between samples, using log 
base 2 and z transformations.  This allows for the determination of sample-specific RNAs.  The 
threshold, which is the cutoff for the number assigned for each gene, denoting specificity and 
presence in the sample, was set to 4.94, any threshold below 4.94 allowed for nonspecific 
mRNAs with a lower p-value.  The 4E3v4E3+CHX analysis was normalized in the same manner 
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as the 4E5v4E3 analysis, with the same threshold of 4.94, with the 4E3v4E3+Tet analysis 
following the previous normalizations of 4E5v4E3, however a threshold value of only 4.3 was 
needed to allow for the elimination of all nonspecific mRNAs. 
 
The gene identifiers of the overrepresented mRNAs were then compared to the TriTryps 
database and their encoded proteins were analyzed with NCBI’s protein BLAST (BLASTp) 
algorithm to determine putative function and homology in relation to other eukaryotes and 
prokaryotes. 
 
The 3’ UTRs of the mRNAs were then analyzed using Trawler (EMBL; 
http://ani.embl.de/trawler/) to examine possible conserved motifs, which would then be used to 
determine possible regulon properties of 4E-5p and 4E-3p.  Trawler examines entered sequences 
from CHiP experiments for recurring segments 5-20 nucleotides in length that are shared 
between two or more entries, and provides the location, nucleotide composition, and motif 
homology with  known transcriptional motifs [46][47].  Sequences in FASTA format were 
generated using the TriTryps database geneID function, selecting the regions of each gene from 
the translation stop codon to the transcription stop.  The background sequence used while 
analyzing the samples was the entire T. brucei genome, used based off of the original paper 
comparing yeast and mammal binding sites, which uncovered novel binding sites and motifs, and 
allowed for a more accurate z-score threshold [47].  Because Trawler was designed for use with 
chromatin-immunoprecipitation (ChiP) data, uracils were represented as thymines in the input. 
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3.7 SECONDARY STRUCTURE PREDICTION OF 3’ UTRS USING RNAFOLD 
The three sample comparisons were used as in the previous experiment; 4E5v4E3, 
4E3v4E3+Tet, and 4E3v4E3+CHX.  Each set of overrepresented mRNAs exhibiting the same 3' 
UTR motif were first run through the TriTryps database again to obtain their 3' UTRs and to 
verify the accuracy of the previous run-throughs.  These 3' UTRs were analyzed individually 
using the RNAfold web server (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) from the Vienna 
RNA Websuite, which has successfully been used in trypanosome studies to analyze structural 
elements for non-coding mRNAs (ncRNAs) predicted through QRNA, to determine the most 
stable 3' UTR structure [48-51].  The minimum free energy (MFE) of the structure and the 
partition function were used to determine the most stable structure with the best base pair 
probability. 
 
The secondary structural elements of the mRNA 3' UTRs generated with the RNAfold 
web server were then analyzed for the specific locations of the shared motifs.  Since the 
RNAfold web server does not number the nucleotides in the secondary structures, the first and 
last nucleotides were determined using the 3' UTR data the TriTryps database provided.  From 
here, the individual nucleotides were counted, with the specific location of the motifs being 
designated from the Trawler outputs. 
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3.8 MOTIF LOCATION USING TRAWLER DATA 
The 3’ UTR mRNA motifs were then analyzed for any structural correlations.  Should 4E-3p 
and/or 4E-5p act directly or indirectly to select for specific mRNAs, these shared motifs would 
need to be accessible.  Bulges and loops provide easier access for any proteins that specifically 
interact with the motifs, so the percent of motif location was determined when the motif 
sequence contained two or more nucleotides residing on the bulge and loop mRNA secondary 
structures in relation to the total number of motifs.   
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4.0  RESULTS 
4.1 IMMUNOFLUORESCENCE 
A previous study has shown that the hypothetical protein encoded by the gene Tb927.10.5020, 
later positively identified as TbeIF4E-5 by our lab, associates with the mitochondrial proteome, 
however further studies have not been conducted to determine its function and confirm the 
cellular location [2][36].  To address this issue, a coimmunofluorescence staining protocol was 
developed.  Possible 4E-5p co-localization with the mitochondrion was compared with the 
known 4E-3p co-localization with the cytoplasm to show the contrast between the two 
localizations by using affinity purified primary antibodies (Ab) specific for 4E-3p or 4E-5p, 
MitoTracker red to stain for the mitochondria, DAPI to stain for the nucleus, and an anti-rabbit 
FITC secondary Ab to determine the locations of the two parasite proteins [6][7].  The 4E-3 
RNAi and 4E-5 RNAi coimmunofluorescence were performed to show the effects of partial 
RNAi knockdown of the respective target proteins in comparison to the cell lines expressing 4E-
3p and 4E-5p at normal levels.  
 
The immunofluorescence data revealed yellow speckled foci (arrows) suggesting an 
association between the uninduced 4E-5p and the mitochondria (Figure 9: 1-5).  These yellow 
foci represent the merging of the Mito stain (red) and the FITC stain (green), which show as a 
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yellow color when the two are co-localized.  By contrast, the data from uninduced 4E-3p shows 
an association with the cytoplasm, consistent with previous studies (Figure 9: 6-10) [52].  The 
RNAi induced 4E-5 and 4E-3 immunofluorescence was shown next to the uninduced 
immunofluorescence to illustrate the effects of protein knockdown on kinetoplast and nuclear 
division, which caused multiple kinetoplasts and nuclei deformations in the parasites, evidenced 
by the multiple nuclei stained by DAPI. 
 
Therefore, these data show evidence for the association of the 4E-5p with the 
mitochondrion of the parasite, depicted by the yellow coloration in the cells, which shows an 
overlap of 4E-5p with the mitochondrion.  The lack of any of these yellow foci in the 4E-3 slides 
shows confirmation that 4E-3p acts in the cytoplasm of the parasite.  The partial knockdown 
immunofluorescence supports previous findings from our lab that a lack of 4E-3p and 4E-5p 
cause deformations in the cell, evidenced by the multiple DAPI-stained nuclei in each cell. 
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Figure 9. Immunofluorescent images.  
 
(A) Immunofluorescent images depicting 4E-5 association with the mitochondrion in normal cells 
(-Tet) and RNAi induced cells (+Tet). (1) Procyclic form T. brucei light microscopy, (2) DAPI 
staining of kinetoplast and nucleus, (3) FITC anti-rabbit IgG against anti-4E-5 antibody, (4) 
MitoTracker Red CMXRos fluorescent dye depicting mitochondrial membrane, (5) merge; yellow 
foci (arrows) indicate co-localization of 4E-5 and mitochondria.  (B) Immunofluorescent images 
depicting 4E-3 association with the cytoplasm in normal cells (-Tet) and RNAi induced cells 
(+Tet). (6) PF T. brucei light microscopy, (7) DAPI staining of kinetoplast and nucleus, (8) FITC 
anti-rabbit IgG against anti-4E-3 antibody, the large green masses are clumps of FITC unrelated to 
the cells, (9) MitoTracker Red CMXRos fluorescent dye depicting mitochondrial membrane, (10) 
merge; general diffusion of 4E-3 in the cytoplasm.   
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4.2 CO-IMMUNOPRECIPITATION 
To determine the specificities of the affinity purified antibodies in order to ensure the most 
efficient pulldown of possible functional translation complexes, a co-immunoprecipitation (coIP) 
procedure was designed and optimized, with western blot analysis used to confirm the complete 
or near-complete pulldown of the target proteins. A low stringency salt solution was used for 
dounce homogenization and preservation of protein-protein interactions.  The pelleted antibody-
protein complexes were washed with a high stringency salt solution to reduce non-specific 
binding, which was later analyzed to determine the specificities of the affinity purified 
antibodies. 
 
A second set of coIP experiments was performed to later assess the associations of 4E-3p 
and 4E-5p with other proteins and with mRNAs.  The low stringency salt solution was used for 
dounce homogenezation, while a moderately stringent salt solution was used to wash the pelleted 
antibody-protein complexes, hopefully preserving the protein-protein interactions, with an 
RNase inhibitor to preserve any associated mRNAs.  Sample 1 was a pulldown using the affinity 
purified anti-4E-5 antibody with the 4E-5 RNAi cell line.  Sample 2 was a pulldown using the 
affinity purified anti-4E-3 antibody with the 4E-3 RNAi cell line.  Sample 3 was a pulldown 
using the affinity purified anti-4E-3 antibody with the 4E-3 RNAi cell line, with the addition of 
cycloheximide to arrest translation.  Finally, sample 4 was a pull down using the affinity purified 
anti-4E-3 antibody with the 4E-3 RNAi cell line, with the addition of tetracycline to partially 
knock down 4E-3p. 
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The western blot analysis of the 4E-3p coIP showed there was almost complete pull down 
of 4E-3p from the total lysate (Figure 10A).  The Sypro Ruby analysis of the 4E-3p coIP shows 
a significant number of proteins associated with the pulldown of 4E-3p containing 
complexes(Figure 10B). 
 
Figure 10. Efficient pulldown of TbeIF4E-3p by rabbit anti-4E-3 Ab and protein A sepharose 
magnetic beads.  
 
(A) Western blotting for the 4E-3p antibody pulldown.  Note immunodepletion of 4E-3p in supernatant, 
which is after the cell lysates being subjected to antibody (Ab) incubation and pulldown (lane 4).  Lane 
1 represents the total cell lysates.  Lane 2 is after the addition of the antibody, denoted by *.  Lane 3 is 
after the addition of protein A sepharose beads.  Lane 4 shows the depletion of 4E-3p with the Ab-bead 
complex.  Lane 5 shows the pelleted 4E-3p-Ab-bead complex.  (B) Sypro-Ruby stain (negative image).  
Note co-IP of multiple proteins (red). Pellets were after 50 mM KCl wash. Lanes are normalized for 
comparison, each representing 1mL of procyclic form culture (107 cells).  Lane 1 depicts the total lysate.  
Lane 2 depicts the 4E-3p-Ab-bead complex. 
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4.3 MASS SPECTROMETRY 
Previous studies have shown the association of the 4E-3p with other proteins in the eIF4F 
complex. However, these experiments have used HA-tagged 4E-3p, the tag possibly interfering 
with the natural protein-protein interactions of 4E-3p.  Furthermore, a comprehensive analysis of 
protein interactions has not been performed.  Previous studies have shown that partial 
knockdown of 4E-3p interferes with cell division and nuclear and kinetoplast face, so we 
hypothesized that 4E-3p associates with other complexes to regulate cell cycle and possibly cell 
growth.  To address this, samples from the optimized coIP experiments were sent out for mass 
spectrometry analysis.  The samples from the coIP used were the Sample 1, denoted 4E-5, as our 
specificity control, Sample 2, denoted 4E-3, and Sample 3, denoted 4E-3+CHX. 
 
Preliminary analysis of the MS data showed unique proteins being pulled down in each 
sample.  Since background noises can never be eliminated, as a baseline for analysis, it was 
recommended by the Biomedical Mass Spectrometry Center that a two-fold difference would be 
accepted as significant difference between samples. Using this criterion, the samples subjected to 
the 4E-3 antibody (Ab) show a significant pulldown of 4E-3p but not 4E-5p, confirming the 
specificity of the antibody being used (Figure 11).  Conversely, the 4E-5 Ab samples showed no 
presence of 4E-3p, yet contained an uncharacterized protein that was consistent with 4E-5p. 
Between the three samples analyzed, there were a greater number of proteins represented in the 
sample treated with the translation inhibitor, cycloheximide (CHX) (Table 1).   
Interestingly, under this condition, a homolog of 4G, identified as TbEIF4G-4 (4G-4 accession 
number Tb927.11.10560) and a homolog of 4A, identified as TbEIF4A-1 (4A-1 accession 
number Tb09.211.3510), an ATP-dependent DEAD/H RNA helicase, were also present in the 
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4E-3 Ab sample pulldown treated with CHX (Figures 12 and 13).  The 4G-4 peptide was 
directly identified from the Tri-Tryp database, whereas 4A peptide was identified using BLAST 
search and peptide alignment, showing a 20% similarity between human eIF4A.  In comparison, 
homology was determined between 4E-3p and yeast 4E protein at 27%. These results are 
consistent with the hypothesized function of 4E-3p as a canonical eIF4E in translation.  This is 
the first in vivo evidence of endogenous 4E-3 association with components of the 4F complex. 
Intriguingly, of the proteins specifically pulled down in the CHX sample, a majority were 
metabolic enzymes. The reasons remain unclear but possible explanations are presented in the 
discussion section.  
 
Ribosomal proteins were also pulled down in all three of the samples in similar 
quantities, regardless of the Ab used, suggesting either non-specific binding or supporting a role 
in translation for both 4E-3p and 4E-5p, confirming 4E-3p and 4E-5p as regulators of translation. 
Of the uncharacterized proteins that were pulled down, two were shown to have similarities with 
proteins already identified in the TriTryps database.  Q587B0 was pulled down in all three of the 
samples, and is verified to be Eukaryotic RNA Binding Protein 42, which binds to the TATA 
box on DNA and assists in RNA polymerase II binding, according to the TriTryps database 
(Figure 14).  Of the other uncharacterized proteins, two were identified using the BLAST 
algorithm through NCBI to show homology in some degree to known eukaryotic proteins.  
Q385C5 was identified in each sample with no significant difference between them, and shows a 
27% homology with the eukaryotic mRNA capping enzyme.  Q581A4, found specifically in the 
4E-5 antibody co-immunoprecipitation sample, was determined using BLAST and the TriTryp 
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database to be the recently discovered 4E-5p, again supporting the specificity of the antibodies 
being used (Figure 15). 
 
The pull down of metabolic enzymes in the 4E-3 CHX sample supports the function and 
importance of the homolog 4E-3 in the growth cycle of trypanosomes, due to the need of 
metabolic enzymes in normal cell processes. 
 
Overall, these data verify the specific pulldown of 4E-5p using the 4E-5 Ab and 4E-3p 
using the 4E-3 Ab.  The association of proteins belonging to the 4F complex when translation is 
arrested in the 4E-3 pulldown using CHX, specifically 4G-4 and 4A, supports 4E-3p as a bona 
fide eukaryotic 4E and is important for translation.  The general association of ribosomal 
proteins in all of the samples support both 4E-3p and 4E-5p as regulators in translation.  The role 
of 4E-5p regulating translation while being associated with the mitochondrion would be 
unprecedented. 
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Figure 11. Chart showing relative area derived from mass spectrometry for eIF4E, verified by the 
TriTryps database to be TbeIF4E-3.   
 
The peptide sequences are the segments the Biomedical Mass Spectrometry Center at the University of 
Pittsburgh verified to belong to this protein.  The area under the peaks for the intensity of the peptide 
sequences is represented by Total Area.  Blue represents the peptide concentrations in the anti-4E-5 
antibody (Ab) sample, red represents the peptide concentrations in the anti-4E-3 Ab sample, and yellow 
represents the anti-4E-3 Ab sample treated with cycloheximide to arrest translation. 
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Table 1.  Table depicting the discovered proteins associated with the target proteins.   
  
 
The first column shows proteins specific for the anti-4E-5 antibody (Ab) pulldown.  The second column shows 
proteins specific for the anti-4E-3 Ab pulldown.  The third column shows proteins specific for the anti-4E-3 Ab 
pulldown treated with cycloheximide (CHX).  This is important as CHX arrests translation and provides a more 
accurate representation of the polypeptides associated with 4E-3p.  The fourth column shows proteins having no 
specificity between the samples. 
 
 
 
 
 
 
Proteins Specific to the 
4E-5 Ab Pulldown 
Proteins Specific to the 
4E-5 Ab Pulldown 
Proteins Specific to the 
4E-5 Ab Pulldown 
Treated with 
Cycloheximide 
Proteins Shared 
Between All Samples 
Nucleosome Assembly 
Protein 
TbeIF4E-3 TbeIF4E-3 Glycosomal Malate 
Dehydrogenase 
Retrotransposon Hot Spot  Elongation Factor 2 60S Ribosomal Protein L1 
Q581A4 – TbeIF4E-5  Q57W90 – High 
molecular weight glutenin 
subunit 
40S Ribosomal Protein SA 
  Fructose Bisphosphate 
Aldolase 
60S Acidic Ribosomal 
Subunit 
  Elongation Factor 1-alpha-
1 
Q587B0 RNA Binding 
Protein 42 
  eIF4A 60S Ribosomal Protein 
L13 
  Q383M3 – eIF4G 40S Ribosomal Protein 
S10 
  Succinyl-CoA: 3-ketoacid-
coenzyme A transferase 
60S Ribosomal Protein L6 
  Pyruvate Phosphate 
Dikinase 
Q385C5 – mRNA 
Capping Enzyme 
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Figure 12. Chart showing relative area derived from mass spectrometry for Q383M3, 
verified by TriTryps database to be eIF4G.   
 
The peptide sequences are the segments the Biomedical Mass Spectrometry Center at the 
University of Pittsburgh verified to belong to this protein.  The area under the peaks for the 
intensity of the peptide sequences is represented by Total Area.  Blue represents the peptide 
concentrations in the anti-4E-5 antibody (Ab) sample, red represents the peptide concentrations in 
the anti-4E-3 Ab sample, and yellow represents the anti-4E-3 Ab sample treated with 
cycloheximide to arrest translation. 
 
 
 
 
 35 
 
Figure 13. Chart showing relative area derived from mass spectrometry for ATP-dependent DEAD/H RNA 
Helicase, or eIF4A.   
 
The peptide sequences are the segments the Biomedical Mass Spectrometry Center at the University of Pittsburgh 
verified to belong to this protein.  The area under the peaks for the intensity of the peptide sequences is represented 
by Total Area.  Blue represents the peptide concentrations in the anti-4E-5 antibody (Ab) sample, red represents the 
peptide concentrations in the anti-4E-3 Ab sample, and yellow represents the anti-4E-3 Ab sample treated with 
cycloheximide to arrest translation. 
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Figure 14. Chart showing relative area derived from mass spectrometry for Q587B0, 
verified by BLASTp algorithm to be homologous to RNA binding protein 42, which binds 
to the TATA box on DNA and assists in RNA polymerase II binding.   
 
The peptide sequences are the segments the Biomedical Mass Spectrometry Center at the 
University of Pittsburgh verified to belong to this protein.  The area under the peaks for the 
intensity of the peptide sequences is represented by Total Area.  Blue represents the peptide 
concentrations in the anti-4E-5 antibody (Ab) sample, red represents the peptide concentrations 
in the anti-4E-3 Ab sample, and yellow represents the anti-4E-3 Ab sample treated with 
cycloheximide to arrest translation. 
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Figure 15. Chart showing relative area derived from mass spectrometry for Q581A4, verified by 
the TriTryps Database and out lab to be TbeIF4E-5.   
 
The peptide sequences are the segments the Biomedical Mass Spectrometry Center at the University of 
Pittsburgh verified to belong to this protein.  The area under the peaks for the intensity of the peptide 
sequences is represented by Total Area.  Blue represents the peptide concentrations in the anti-4E-5 
antibody (Ab) sample, red represents the peptide concentrations in the anti-4E-3 Ab sample, and yellow 
represents the anti-4E-3 Ab sample treated with cycloheximide to arrest translation. 
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4.4 RNASEQ ANALYSIS OF 4E-3 AND 4E-5 ASSOCIATED MRNA 
Because of the confirmed association of 4E-3p with the components of the eIF4F complex and 
the confirmed identity of 4E-5p as a eukaryotic initiation factor, an experiment was performed to 
further determine the roles 4E-3p and 4E-5p play in the T. brucei cell viability and proper cell 
division, specifically through cell cycle regulation and gene expression.  Therefore, samples 1 
through 4 from the coIP experiment were analyzed using RNAseq.  RNAseq quantifies the total 
mRNA from a given sample and provides known identities, which was important for these 
purposes to provide a snapshot of what mRNAs 4E-3p and 4E-5p were associated with and 
which mRNAs were present in higher quantities in each sample, either as general or specific 
translation initiators. 
 
Preliminary results of the RNAseq performed by Rahil Sethi at the Bioinformatics Core 
Facility showed a roughly equal amount of unique mRNAs pulled down in each sample.  There 
were two reference strains used to map the mRNA, Treu927 and Lister427.  Each reference 
strain covered different unique sets of mRNA, so both were used to provide the highest amount 
of coverage.  Both Burrows-Wheeler Aligner (BWA), which is bidirectional and functions well 
for ungapped reads, and Bowtie, which performs well with gapped reads, were used to ensure 
full coverage of the mRNAs in each sample [44].  All of the mappers used the fragment library 
type.   
 
Bowtie mapping using the reference TREU927 provided 19,067,853 reads for the 4E-5 
Ab pulldown, of which 14,057,831 were mapped and 382,434 were unique.  BWA using 
TREU927 for the 4E-5 Ab pulldown provided 19,067,853 reads, 9,583,154 mapped reads, while 
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285,465 were unique.  Bowtie mapping using Lister427 for the 4E-5 Ab pulldown provided 
19,067,853 reads, 14,052,188 mapped reads, and 381,475 uniquely mapped reads.  BWA using 
Lister427 for the 4E-5 Ab pulldown provided 19,067,853 reads, of which 9,622,037 were 
mapped and 329,076 were unique. 
 
Bowtie mapping using the reference TREU927 provided 20,653,837 reads for the 4E-3 
Ab pulldown, of which 13,906,156 were mapped and 405,544 were unique.  BWA using 
TREU927 for the 4E-3 Ab pulldown provided 20,653,837 reads, 9,597,554 mapped reads, while 
303,611 were unique.  Bowtie mapping using Lister427 for the 4E-3 Ab pulldown provided 
20,653,837 reads, 13,910,505 mapped reads, and 405,931 uniquely mapped reads.  BWA using 
Lister427 for the 4E-3 Ab pulldown provided 20,653,837 reads, of which 9,662,124 were 
mapped and 358,133 were unique. 
 
Bowtie mapping using the reference TREU927 provided 11,927,415 reads for the 4E-3 
Ab pulldown treated with the translation inhibitor cycloheximide (CHX), of which 7,786,455 
were mapped and 219,817 were unique.  BWA using TREU927 for the 4E-3 Ab pulldown 
treated with CHX provided 11,927,415 reads, 5,092,635 mapped reads, while 155,471 were 
unique.  Bowtie mapping using Lister427 for the 4E-3 Ab pulldown treated with CHX provided 
11,927,415 reads, 7,789,011 mapped reads, and 220,012 uniquely mapped reads.  BWA using 
Lister427 for the 4E-3 Ab pulldown treated with CHX provided 11,927,415 reads, of which 
5,117,568 were mapped and 180,168 were unique. 
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Bowtie mapping using the reference TREU927 provided 12,686,034 reads for the 4E-3 
Ab pulldown treated with tetracycline (Tet), of which 8,814,488 were mapped and 199,544 were 
unique.  BWA using TREU927 for the 4E-3 Ab pulldown treated with Tet provided 12,686,034 
reads, 5,594,119 mapped reads, while 138,332 were unique.  Bowtie mapping using Lister427 
for the 4E-3 Ab pulldown treated with Tet provided 12,686,034 reads, 8,817,039 mapped reads, 
and 199,922 uniquely mapped reads.  BWA using Lister427 for the 4E-3 Ab pulldown treated 
with Tet provided 12,686,034 reads, of which 5,633,827 were mapped and 177,423 were unique. 
 
This indicated that there was a very good coverage of reads, although the percent of 
uniquely mapped segments of RNA were low, indicating a significant amount of ambiguous 
mapping of reads. 
4.5 BIOINFORMATIC ANALYSIS OF RNASEQ DATA 
The preliminary RNAseq data were then analyzed to determine if there were overrepresented 
mRNAs specific to each sample.  To do this, the samples were compared against the 4E-3 
antibody pulldown as a specificity control in 4E5v4E3 and as negative controls for 
4E3v4E3+CHX and 4E3v4E3+Tet.  The first comparison, denoted 4E5v4E3, compared the 
pulldown of 4E-5p, Sample 1, with the 4E-3p pulldown Sample 2, allowing for the determination 
of overrepresented mRNAs specific to 4E-5p relative to 4E-3p and vice versa.  The second 
comparison, denoted 4E3v4E3+CHX, compared the pulldown of the untreated 4E-3p, Sample 2, 
with the 4E-3p pulldown treated with cycloheximide, Sample 3, possibly showing 
overrepresented mRNAs captured during translation inhibition.  The third comparison, denoted 
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4E3v4E3+Tet, compared the pulldown of the untreated 4E-3p, Sample 2, with the 4E-3 RNAi 
tetracycline-induced pulldown, Sample 4, to show possible reduction of mRNAs that regulate 
cell cycle and gene expression when 4E-3p is partially knocked down.  The caGEDA program 
identified 313 mRNAs that were overrepresented in all of the samples.  The TriTryps database  
was used to identify verified mRNAs, while using the BLASTp algorithm to assign putative 
function of mRNAs that were unidentified, comparing the polypeptide sequences retrieved from 
the TriTryps database encoded by the mRNA to known eukaryotic and prokaryotic proteins, with 
a few hypothetical unknowns in each sample. 
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Table 2.  Overrepresented mRNAs discovered by RNAseq and caGEDA in the anti-4E-5 Ab pulldown.   
 
 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis).  A total of 5 variable surface glycoproteins (VSGs) and 12 hypothetical unknowns 
were also discovered. 
 
Predicted 
Encoded 
Protein 
Function 
Gene 
Identifier 
Quantity 
Greater 
Than 
Threshold 
Predicted Encoded Protein 
Cell Cycle Tb10.26.0300 6% S-phase kinase-associated protein 1 Tb09.244.2520 5% Bloodstream stage alaninerich protein BARP 
General 
Gene 
Expression 
Tb927.6.110 59% DNA polymerase 
Tb927.4.510 58% DNA directed RNA polymerase subunit 
Tb11.57.007  37% RNA Directed DNA Polymerase 
Tb10.70.6250  27% Bifunctional DNA Primase/Polymerase 
Tb10.100.0045 20% Type II Restriction Enzyme Kpn1 
Misc Tb11.01.7005 45% TRAP dicarboxylate transporter DctQ subunit Tb927.7.4680 11% Phosphoprotein lepp12 
Misc Signal  Tb927.1.2985 16% Multisensor signal transduction histidine kinase 
Misc 
Membrane  
Tb927.4.140 105% Lipoporein release system 
Tb10.389.0760 6% Membrane transporter  
Misc 
Transporter  Tb11.17.0004 153% Major facilitator transporter 
Misc 
Metabolism 
Tb09.142.036 136% Catabolite activator protein 
Tb927.7.7560 68% Peptidase S9 
Tb927.8.3780 47% Ubiquinone/plastoquinone oxidoreductase chain 6 
Tb927.7.3840 25% Kinesin-like protein fragment 
Tb10.61.3155 24% Trans-sialidase 
Tb927.1.4950 20% Glutathione S-transferase 
Tb927.4.3830 17% Argininosuccinate synthase 
Tb927.3.2260 6% Hyaluronate lyase 
Tb10.70.2890 4% Patatin-like phospholipase domain-containing protein 1-like 
Tb927.6.250 2% Peptidase M28 
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The 4E5v4E3 sample showed a larger number of mRNAs that encode for proteins that 
assist in gene expression and mRNAs that encode proteins for RNA metabolism in the 4E-3 
specific sample (Tables 2-4).  Among these RNA metabolism mRNAs were 4A, which is part of 
the eIF4F complex, and a putative DNA directed RNA polymerase II subunit, which produces 
mRNA from the DNA, with less than 1% higher presence than the baseline, meaning that 
although there is over a 95% confidence that these are specific for the 4E-3 specific sample, 
although are not highly overrepresented.  There were also a number of mRNAs coding for 
putative mitochondrial proteins, with up to 45% higher presence than the baseline.  Among the 
other mRNAs specific to the 4E-3 sample were a number of putative membrane and transport 
proteins.  
 
The 4E-5 specific sample contained putative general gene expression mRNAs, but with 
an emphasis on polymerases, such as DNA polymerase with a 58% higher presence than the 
baseline, RNA directed DNA polymerase with a 37% higher presence than the baseline, and a 
bifunctional DNA primase/polymerase with a 27% higher presence than the baseline.  Of note 
are mRNAs that encode for the putative S-phase kinase-associated protein 1, which assists with 
cell division, and the verified blood stream alaninerich protein (BARP), which are key for the 
blood form stage of the parasite, at 6% and 5% higher presence than the baseline, respectively.  
Both samples contained a roughly equal number of cell cycle, metabolic and variable surface 
glycoprotein (VSG) mRNAs (Table 2). 
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Table 3. Part 1. Overrepresented mRNAs discovered by RNAseq and caGEDA in the anti-4E-3 Ab pulldown.   
 
 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis). A total of 6 variable surface glycoproteins (VSGs) and 24 hypothetical unknowns 
were also discovered. (Continued on Table 4). 
Predicted Encoded 
Protein Function Gene Identifier 
Quantity 
Greater Than 
Threshold 
Predicted Encoded Protein 
Cell Cycle 
Tb927.4.390  18% Cell Division Protein 
Tb927.7.5780  6% GO function: Cell redox homeostasis 
RNA Metabolism 
Tb927.6.1710  16% DEAD/DEAH Box Helicase 
Tb427.10.7190  12% D-tyrosyl tRNA deacylase 
Tb927.7.370  10% tRNA Ligase Class I 
Tb927.3.5500  <1% DNA Directed RNA Polymerase II Subunit 3C 
General Gene 
Expression 
Tb11.57.007  110% RNA Directed DNA Polymerase 
Tb927.4.120  91% Type III Restriction Endonuclease Subunit R 
Tb927.2.900  40% Type III Restriction Endonuclease Subunit R 
Tb10.70.3330  39% Protein dpy-30 Homolog 
Tb09.211.0485  35% DNA Mismatch Repair Protein 
Tb10.70.2020 26% Zinc Finger Protein Family 
Tb927.3.5230  14% DNA Repair Protein C 
Tb10.61.0490  12% rRNA Processing Protein 
Tb927.8.2560  10% Spliceosomal U5 snRNP-specific Protein 
Tb927.2.1250  8% Type III Restriction Endonuclease Subunit R 
Tb927.1.1410  7% Histidine Kinase 
Tb10.70.2550  4% Transcription Elongation Factor S-II-Related Protein L122 
Misc-Mitochondrial 
Tb10.406.0615  45% Dynein Light Chain 
Tb927.8.6590  21% Protein targeting to mitochondrion/mitochondrial outer membrane 
Tb927.7.5910  10% ATG8 Ubiquitin-like Protein 
Tb927.6.4580  10% Mitochondrial SSU Ribosomal Protein 
Tb11.02.3065  2% Mitochondrial Translocase Subunit 
Tb927.4.830  1% Cytochrome C Oxidase Assembly Factor 5-like 
Misc-Flagellar  Tb10.70.7560  17% TAX-2 Flagellar Protein 
Misc-Membrane  
Tb927.4.140  143% Lipoporein Release System 
Tb927.1.1760  38% EXS Family Protein 
Tb927.3.3700  28% Sodium/hydrogen Exchanger  
Tb10.61.0870  25% SNARE Protein 
Tb11.02.0390  15% Mechanosensitive Ion Channel Protein Msc5 
Tb11.01.7790  8% Signal Recognition Particle 
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Table 4. Part 2. Continuation from Table 3. 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis).  
 
 
Predicted 
Encoded 
Protein 
Function 
Gene 
Identifier 
Quantity 
Greater 
Than 
Threshold 
Predicted Encoded Protein 
Misc-
Transport 
Protein 
Tb10.389.1570  24% RAB Interacting Protein 
Tb927.4.4780  14% Ran-Binding Protein 9 Isoform X3 
Tb927.4.2100  5% Transferrin Receptor Protein 2 Isoform X1 
Tb09.211.1195  5% Phosphatylcholine:Ceramide Cholinephosphotransferase 2 
Tb09.244.1910  4% Phosphate ABC Transporter Permease 
Tb927.8.6570  4% Binding-Protein-Dependent Transport System Inner Membrane Component 
Misc-
Metabolism 
Protein 
Tb927.1.360  102% Peptidase U32 
Tb927.7.7560  68% Peptidase S9 
Tb09.244.2770  54% Oxysterol-binding protein-related Protein 6 
Tb927.1.110   36% Acetylneuraminic Acid Synthase 
Tb927.3.4480  36% ATP Synthase F1 Subunit Gamma 
Tb927.5.1040  32% Short-Chain Dehydrogenase/Reductase 
Tb927.5.3740  31% Ring-box Protein 1 
Tb11.02.0865  25% Thioesterase Superfamily 
Tb11.01.7560  23% Glutathione Peroxidase 
Tb09.211.4500  22% Trans-sialidase 
Tb927.6.110 19% 43% Lysozyme  
Tb927.4.1520  15% FAM206A 
Tb927.3.2970  14% Pyridoxal-5'-phosphate-dependent Protein Subunit Beta 
Tb927.4.150  12% Segregation and Condensation Protein A 
Tb10.389.0300  5% Mannosyl Transferase II 
Tb927.4.3630  3% Protein Phosphatase 1 
Tb09.354.0020  3% Glutamate Synthase 
Tb927.1.4490  2% Acetyltransferase 
Tb927.7.340  2% Abhydrolase Domain-Containing Protein 11 
Tb927.7.310  1% Glutathione S-transferase/Glutaredoxin 
Tb11.01.0290  1% Carbonic Anhydraselike Protein 
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Table 5. Overrepresented mRNAs discovered by RNAseq and caGEDA in the anti-4E-3 Ab pulldown treated 
with the translation inhibitor cycloheximide in comparison to the untreated anti-4E-3 Ab pulldown.   
 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis). A total of 20 variable surface glycoproteins (VSGs) and 4 hypothetical unknowns 
were also discovered. 
 
 
 
 
 
Predicted 
Encoded 
Protein 
Function 
Gene 
Identifier 
Quantity 
Greater 
Than 
Threshold 
Predicted Encoded Protein 
RNA 
Metabolism Tb927.1.390  8% RNA Helicase 
Misc N/A  36% snRNA U2 
Misc-Flagellar Tb927.7.3840  16% Kinesin-like Protein Fragment - Microtubule-based Movement 
Misc-
Membrane  Tb927.1.200  4% 
Binding-Protein-Dependent Transport Systems 
Inner Membrane Component 
Misc-Transport  Tb927.1.2985  23% Multisensor Transduction Histidine Kinase Tb927.6.3910  1% STELAR K+ Outward Rectifier Isoform 2 
Misc-
Metabolism 
Tb927.4.510  55% Molybdopterin Converting Factor Subunit 2 
Tb927.8.1660  35% Procyclin-Associated Gene 
Tb927.1.2620  35% Bariochlorphyll 4-vinyl Reductase 
Tb927.6.110  31% Lysozyme 
Tb927.4.2420  29% ATP Binding Transporter 
Tb927.8.5550  21% Fe(3+) Ions Import ATP-Binding Protein FbpC 
Tb927.1.230  9% Phosphoterase 
Tb927.1.3510  2% Integral Membrane Sensor Hybrid Histidine Kinase 
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Table 6. Overrepresented mRNAs discovered by RNAseq and caGEDA in the anti-4E-3 Ab pulldown in 
comparison to the anti-4E-3 Ab pulldown treated with the translation inhibitor cycloheximide.   
 
 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis). A total of 1 variable surface glycoproteins (VSGs) and 2 hypothetical unknowns 
were also discovered. 
 
 
 
 
 
 
Predicted 
Encoded 
Protein 
Function 
Gene 
Identifier 
Quantity 
Greater 
Than 
Threshold 
Predicted Encoded Protein 
General Gene 
Expression 
Tb927.4.120  22% Type III Restriction Endonuclease Subunit R 
Tb927.5.1360  21% Nucleoside 2-deoxyribosyltransferase (NDRT) 
Misc 
Tb927.1.1400  16% OPI10-like Protein 
Tb927.7.2730  13% Leucine Rich Repeat Protein 
Tb927.7.1380  8% Calpain-like Cysteine Peptidase 
Tb927.4.2530  5% DoxX Protein 
Misc-
Mitochondrial Tb927.8.6570  19% YLR356Wp - uncharacterized mitochondrial protein 
Misc-Signal  Tb927.1.1760  21% EXS Family Protein 
Misc-
Membrane  Tb927.6.530  1% Procyclin Associated Gene 3 
Misc-
Transport  
N/A  26% Got1 Homolog 
Tb927.8.1320  14% QA-Snare Protein 
Tb927.8.5900  4% Trafficking Protein Particle Complex 2 
Misc-
Metabolism 
Tb927.5.1040  5% NADPH-dependent FMN Reductase 
Tb927.4.1520  1% FAM206A 
Tb927.4.2610  <1% Phosphoserine Transaminase 
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The 4E3v4E3+CHX comparison was denoted as 4E-3+CHX Increase, for the sample that 
was treated with CHX, versus 4E-3+CHX Decrease, for the sample that was just the pulldown 
with the 4E-3 Ab, to determine if the addition of CHX captured additional or unique mRNAs 
(Tables 5 and 6).  Of note in the 4E-3+CHX Increase sample was the presence of mRNA 
encoding for a putative RNA helicase, with an 8% higher presence than the baseline, and a large 
number of putative metabolic mRNAs and VSGs (Table 5).   
 
In the sample 4E-3+CHX Decrease sample, there was a large number of miscellaneous 
mRNAs and two general gene expression mRNAs.  The general gene expression mRNAs were a 
putative nucleoside 2-deoxyribosyltransferase (NDRT), with a 21% higher presence than the 
baseline, and a verified Type III restriction endonuclease subunit R, with a 22% higher presence 
than the baseline, the latter of which was also in the 4E-3 sample in the 4E5v4E3 comparison 
(Table 6).   
 
In the comparison 4E3v4E3+Tet, the samples were denoted as 4E-3+Tet Increase, to 
denote the mRNAs increased in the presence of Tet, and 4E-3+Tet Decrease, to denote the 
mRNAs decreased in the presence of Tet in the 4E-3 pulldown that was untreated (Tables 7 and 
8).  In the 4E-3+Tet Increase sample, there was a large number of VSG and putative metabolism 
mRNAs.  There was the presence of two putative RNA metabolism mRNAs and mRNAs that 
encode for putative gene expression proteins, however only one putative general gene expression 
mRNA was of note, which is the putative RNA-editing complex, with a less than 1% higher 
presence than the baseline (Table 7).   
 
 49 
For the sample 4E-3+Tet Decrease, there was the presence of a large number of general 
gene expression mRNAs, such as the putative DNA-binding helix-turn-helix protein, with a 2% 
higher presence than the baseline, and putative DNA directed RNA polymerase II subunit 
mRNAs, with 27% higher presence than the baseline, a few putative mitochondrial mRNAs, and 
putative cell cycle mRNAs.  Of extreme importance was the presence of a verified 4E mRNA, 
however the identity is undetermined at this time (Table 8). 
 
 From these data, a general sense of 4E-5p and 4E-3p can be suggested through their 
specific mRNA targets.  The 4E-5p appeared to associate with mRNAs encoding for proteins key 
for cell division, specifically DNA polymerase and S-phase kinase-associated protein 1, while 
also associating with mRNAs that encode for transcriptional regulators, such as the RNA 
polymerase and the DNA primase.  In comparison, 4E-3p appeared to associate with mRNAs 
that encode for proteins that perform a variety of cell functions, such as the 4A and the DNA and 
RNA polymerases which are key for transcription and translation, and lysozymes and peptidases 
that assist with cell metabolism and general function. 
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Table 7. Overrepresented mRNAs discovered by RNAseq and caGEDA in the anti-4E-3 Ab pulldown treated 
with tetracycline to partially knockdown 4E-3p in comparison to the anti-4E-3 Ab pulldown.   
 
 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis). A total of 32 variable surface glycoproteins (VSGs) and 11 hypothetical unknowns 
were also discovered. 
Predicted 
Encoded Protein 
Function 
Gene Identifier 
Quantity 
Greater Than 
Threshold 
Predicted Encoded Protein 
RNA Metabolism Tb927.1.1490  20% 
Branched-chain Amino Acid Transport System Carrier 
Protein 
Tb927.1.2870  17% Peptidase M20 
General Gene 
Expression 
Tb927.6.810  29% Y53C12B.7 
Tb927.1.2860  11% Transposon Tn7 Transposition Protein TnsC 
Tb927.8.680  <1% RNA-Editing Complex (KREPA 5) 
Misc 
Tb927.7.7550  63% Potassium Channel Subfamily K Member 16 
Tb927.1.3570  23% Arabinose Efflux Permease Family Protein 
Tb927.1.3720  18% Probable Protein Phosphatase 2C 4-like 
Misc-
Mitochondrial Tb927.1.1810  44% Cytochrome C Oxidase Subunit II, Partial 
Misc-Flagellar Tb927.1.1860 24% Flagellar Biosynthetic Protein FlhB Tb927.7.3840  15% Kinesin-like Protein Fragment 
Misc-Membrane 
Protein 
Tb927.4.140  67% Lipoporein Release System 
Tb927.1.200  42% Binding-Protein-Dependent Transport System, Inner Membrane Component 
Tb927.1.3510  5% Integral Membrane Sensor Hybrid Histidine Kinase 
Misc-Transport Tb927.1.4270  17% Protein Transport Protein SEC13 Tb927.1.4950  14% ABC Transporter, ATP-binding Protein 
Misc-Metabolism 
Tb927.1.3750  89% Exopolysaccharide Biosynthesis Protein 
Tb927.7.6870  77% Exopolysaccharide Biosynthesis Protein 
Tb09.v2.0450  60% Exopolysaccharide Biosynthesis Protein 
Tb.927.1.3610  55% Nitrite Reductase 
Tb927.1.3350  53% Halocyanin 
Tb927.1.110  39% Acetylneuraminic Acid Synthetase 
Tb927.8.1660  37% Procyclin-Associated Gene 
Tb927.6.110  32% Lysozyme 
Tb927.1.4670  15% Ca++-ATPase 
Tb927.6.260  14% Long-Chain-Fatty-Acid-CoA Ligase 
N/A  10% Ferrodoxin 
Tb927.1.3630  9% GTPase-activator Protein for Ras Family GTPase 
Tb11.40.0010  7% Glycosyltransferase 
Tb927.4.3830  4% Argininosuccinate Synthase 
Tb927.7.6020  3% Alpha-Amylase Family Protein 
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Table 8. Overrepresented mRNAs discovered by RNAseq and caGEDA in the anti-4E-3 Ab in comparison to 
the anti-4E-3 Ab pulldown treated with tetracycline to partially knockdown 4E-3p.   
 
 
 
The mRNA identities were verified via the TriTryps database.  Any mRNAs not identified by TriTryps were then 
analyzed for their predicted encoded polypeptide sequences, which were examined for homology with other known 
eukaryotic and prokaryotic proteins via the BLASTp algorithm.  The first column shows the predicted encoded 
protein function, based off of either the verified protein’s function or the predicted homologous protein’s function.  
The second lane is the gene identifier provided by the Bioinformatics Core Facility at the University of Pittsburgh 
that identifies which mRNAs were overrepresented.  The quantity greater than threshold is the amount of the 
overrepresented mRNA above the threshold.  The threshold was the cutoff value that ensured only overrepresented 
mRNAs were selected in each sample by caGEDA.  Any value lower than that threshold represented a nonspecific 
mRNA.  The predicted encoded protein is the verified or putative protein encoded by the overrepresented mRNA.  
(See text for in depth analysis). A total of 0 variable surface glycoproteins (VSGs) and 1 hypothetical unknown were 
also discovered. 
Predicted 
Encoded 
Protein 
Function 
Gene 
Identifier 
Quantity 
Greater 
Than 
Threshold 
Predicted Encoded Protein 
Cell Cycle Tb927.8.2320  30% Dedicator of Cytokinesis 11-like Tb927.6.5020  8% Cyclin 7 
RNA 
Metabolism 
Tb927.6.420  55% Non-ribosomal Peptide Synthase 
N/A  8% 4E 
General Gene 
Expression 
Tb927.8.4830  47% U1 snRNP 
N/A  27% DNA-Directed RNA Polymerase II Subunit 
Tb927.8.4130  23% Class I Transcription Factor A Subunit  
N/A  9% snRNP 
Tb927.5.4030  3% U6 snRNA-associated Sm-like Protein Lsm7p 
Tb927.6.590  2% DNA-binding Helix-turn-helix Protein 
Misc 
Tb927.7.5010  19% Arabinose Efflux Permease Family Protein 
Tb927.8.4630  16% Rho Guanine Nucleotide Exchange Factor 5 
Tb927.7.260  11% Chemotaxis Protein 
Tb927.4.3960  9% Relaxase 
Misc-
Mitochondrial 
Tb927.7.2690  43% Mitochondrial Part 
Tb927.8.6190  16% Mitochondrial Conserved Eukaryotic Protein 
Tb927.5.3740  15% E3 Ubiquitin Ligase Protein 
Misc-
Membrane  Tb927.1.650  36% Membrane Protein 
Misc-Transport  
N/A  24% Protein Transport Protein Sec61 Gamma Subunit 
Tb927.7.5900  21% ATG8/AUG7/APG8/PAZ2 
Tb927.7.5910  20% ATG8/AUG7/APG8/PAZ2 
Misc-
Metabolism 
Tb927.6.2120  52% Beta-Glucosidase-like Glycosylhydrolase 
Tb927.6.2990  50% Methylenetetrahydrofolate Dehydrogenase 
N/A  46% Dolichyl-phosphate Beta-D-Mannosyltransferase 
Tb927.1.1770  31% Glutaredoxin 
Tb927.8.4130  23% Histidinol-Phosphate Aminotransferase 
Tb927.8.5320  4% L-arabinose Utilization Protein, Glycerol Dehydrogenase 
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4.6 COMPARISON OF 3’ UTRS TO DETERMINE COMMON MOTIFS  
Once overrepresented mRNAs specific to each sample were determined and verified through 
RNAseq, analyzing the common motifs was crucial to determine whether 4E-3p and 4E-5p act 
on regulons by interaction with mRNA 3' untranslated regions (UTR), separately or in sequence, 
for cell cycle and cell growth.  Since all of the genes are transcribed at once in trypanosomes, a 
majority of the transcripts are stored in transcription vesicles, activated later through 
environmental factors [55].  This would require hypothetical common motifs shared amongst 
functionally relevant mRNA 3' UTRs, allowing for recognition by translation initiation proteins 
or ribonucleic proteins (RNPs).  The key argument behind the search for common motifs was 
based on previous evidence that 4E homologs are required for mRNA transportation out of the 
nucleus, translation initiation and regulation, and mRNA storage [24][53][54].  With 4E-3p and 
4E-5p being shown to be key to cell survival in previous papers [S.Tarun and J. Rocco, data not 
shown], the mass spectrometry (MS) results showing association of 4E-3p with other members 
of the eIF4F complex, and RNAseq showing the association of 4E-3p and 4E-5p to distinct 
mRNAs encoding for key proteins related to cell survival and proteins production, 4E-3p and 
4E-5p may interact with their own unique, conserved motifs present in the 3’ UTR of mRNA to 
assist in recognition and selection of transcripts required by the cell.  
 
The program Trawler (EMBL)(http://ani.embl.de/trawler/) was selected to analyze 
functional sites in the 3’ UTR of the mRNAs based on previous experiments in trypanosomes 
[46][47].   Trawler’s intended use was to analyze large scale chromatin-immunoprecipitation 
data (ChIP), however RNAseq data can be used as well.  Because of this, any uracils present in 
the mRNA are represented by thymines in the motif data presented.  The key inputs for Trawler 
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needed to be in FASTA formatting, obtained via the TriTryp.db website.  The gene identifier of 
each overrepresented mRNA was entered into the geneID search, grouped by which sample the 
mRNA was overrepresented in, and then the 3’ UTRs were selected from the translation stop to 
the transcription stop codons.  These data were then analyzed using Trawler against the reference 
sequence, also in FASTA formatting, of the entire T. brucei genome.  The parameters for motif 
analysis were left with the default settings, and are as follows: the minimum occurrence of the 
motif in the sample was 10; the motif length was a minimum of 6 nucleotides; and the strand 
selection was left at single-stranded since this was mRNA. 
 
 
Figure 16. Motifs specific for mRNA overrepresented in 4E-5.  
 
(A) Graphical representation of mRNA motif nucleotide composition for mRNAs overrepresented in the anti-4E-5 
Ab pull down in comparison to the anti-4E-3 Ab pull down. (B) List of mRNAs pulled down with their function, 
gene identifier, name, and whether they are experimentally Verified or Putative. 
 
 
The output from Trawler contained a graphical depiction of each motif family specific for 
the 3’ UTRs from mRNA overrepresented in each sample, the possible identity of the motif 
based off of motifs in other organisms, or percent relevance, and the motif location for each 
mRNA.  The possible motif identity was not relevant to this study due to the identifications 
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being DNA motifs, however they could reveal associations of ribonucleic proteins (RNPs) or 
eIF4Es with the double stranded DNA, and have been included in the supplement.  Each motif 
length was designated 1 or -1, with the former representing the motif being from the 5’-3’ strand, 
and the latter representing the 3’-5’ strand, due to Trawler comparing the single stranded 
sequences to the double stranded background sequence and providing both directional strands for 
reference.  Since the samples were single-stranded mRNA, only motifs exhibiting a positive 
value were selected.  While not every mRNA that was determined to be overrepresented in each 
sample was present in the Trawler output and shared common 3’ motifs, a large majority were. 
 
The 4E-5 specific sample, from the 4E5v4E3 comparison, showed only one common 
motif family, denoted 4E-5 Specific Family 1 (Figure 16A).  This motif family was heavily 
composed of uracils, again depicted by Trawler using thymines.  The motif was also commonly 
found near the beginning of the 3’UTR, with multiple copies existing from the beginning to the 
middle of the 3’ UTR in each mRNA (Figure 16B).   
 
The 4E-5 Specific Family 1 motif was identified by Trawler to be similar to a wide range 
of DNA motifs, with a few being irrelevant and related to embryogenesis.  Of note, the motif 
identity with the highest divergence was MA0054, having no known function aside from 
transcription factor binding [56].  The motif also had a divergence of 0.77 with a nuclear 
receptor, allowing for the up or down regulation of the mRNA through interaction with nuclear 
proteins [57].  The DNA motif identities with a divergence higher than 0.600 were all related to 
cell proliferation, differentiation, cell cycle control, cell migration, apoptosis, or expression 
regulation (Table S1).  The proteins encoded by the mRNAs that shared the 4E-5 Specific 
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Family 1 motif had predicted functions ranging from cell cycle regulation to general gene 
expression to metabolism.  Of note are the putative type II restriction enzyme Kpnl, a putative 
bifunctional DNA primase/polymerase, a putative DNA directed RNA polymerase subunit, and a 
putative ubiquinone/plastiquinone oxidoreductase chain 6 (Table S1). 
 
 
Figure 17. Motifs specific for mRNA overrepresented in 4E-3.  
 
(A) Graphical representation of mRNA motif nucleotide composition for mRNAs overrepresented in the anti-4E-3 
Ab pull down in comparison to the anti-4E-5 Ab pull down. (B) List of mRNAs pulled down with their function, 
gene identifier, name, and whether they are experimentally Verified or Putative. 
 
 56 
The 4E-3 specific sample, from the 4E5v4E3 comparison, showed seven different 
families of shared motifs, each having a roughly equal composition of purines and pyrimidines 
(Figure 17A).  Three different mRNAs, each encoding for a verified type III restriction 
endonuclease subunit R, were found to have each family of motifs located in the same area and 
within the same range in each mRNA.  A fourth mRNA, encoding for an ATG8 ubiquitin-like 
protein, contained only 4E-3 Specific Family 6’s motif (Figure 17B).   
 
Trawler discovered only one possible DNA motif related to 4E-3 Specific Family 1, Sox-
5, which has embryonic functions and plays a role in cell fate determination, with a divergence 
of 0.808 [58].  4E-3 Specific Family 2 had two possible DNA motif matches, Ma0095 and 
MA0094, both with unknown functions aside from transcription factor binding, and divergences 
of 0.661 for the former and 0.585 for the latter [56].  4E-3 Specific Family 3 had three possible 
DNA motif matches, the one with the highest divergence being bZIP-CREB at 0.898, which 
plays a role in regulation and promotion of expression [59].  The next highest, at a divergence of 
0.862, was c-FOS, which converts extracellular signals into changes of gene expression [60-62].  
The third and final possible identity for Family 3 was MA0086, at a divergence of 0.637, 
however having no known function aside from transcription factor binding [56].  4E-3 Specific 
Family 6 had two possible DNA motif matches for motif identification, Ubx and S8.  Ubx, at a 
divergence of 0.571, allows for ubiquitin protein binding and regulates alternative splicing, while 
S8, with a divergence of 0.415, which binds to the S section of the 30S ribosomal subunit  
(Table S2) [63][64]. 
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Figure 18. Motifs specific for mRNA overrepresented in 4E-3 in the presence of CHX.  
 
(A) Graphical representation of mRNA motif nucleotide composition for mRNAs overrepresented in the anti-4E-3 
Ab pull down treated with cycloheximide (CHX) in comparison to the anti-4E-3 Ab pull down. (B) List of mRNAs 
pulled down with their function, gene identifier, name, and whether they are experimentally Verified or Putative. 
 
The 4E-3 sample treated with CHX, from the 4E3v4E3+CHX comparison and 
representing the mRNAs increased when treated with CHX, showed only one common motif 
family, which was rich in uracils and adenines (Figure 18A).  Sharing this motif, 4E-3 +CHX 
Specific Family 1, were only four mRNAs, encoding for a putative multisensory transduction 
histidine kinase, a putative STELAR K+ outward rectifies isoform 2, a putative molybdopterin 
converting factor subunit 2, and a putative Fe(3+) ion import ATP-binding protein FbpC.  The 
mRNAs encoding for the putative multisensory transduction histidine kinase and putative Fe(3+) 
ion import ATP-binding protein FbpC had the motif located roughly in the center of the 3’ UTR, 
while the mRNAs encoding for the putative STELAR K+ outward rectifier isoform 2 and 
putative molybdopterin converting factor subunit 2 had the motif located near the start of the 3’ 
UTR (Figure 18B).   
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A large number of possible DNA motif identities were provided by Trawler, with varying 
divergences.  Of note were: bZIP- CEBP, which assists in regulation and promotion of 
expression, at a divergence of 0.769; TRP MYB, which assists in secondary metabolism and cell 
shape and fate, at a divergence of 0.727; homeo box, which encodes for transcription factors that 
typically turn on other genes, at a divergence of 0.578; MA0033, with no known function, at a 
divergence of 0.574; HMG-box, which allows for high mobility group (HMG) protein binding to 
affect formation and function of transcription complexes, at a divergence of 0.546; and Ubx, 
which allows for ubiquitin protein binding to regulate alternative splicing, at a divergence of 
0.483 (Table S3) [56][59][63][65-67]. 
 
 
Figure 19. Motifs specific for mRNA overrepresented in 4E-3 in the absence of CHX.  
 
(A) Graphical representation of mRNA motif nucleotide composition for mRNAs overrepresented in the anti-4E-3 
Ab pull down in comparison to the anti-4E-3 Ab pull down treated with cycloheximide (CHX). (B) List of mRNAs 
pulled down with their function, gene identifier, name, and whether they are experimentally Verified or Putative. 
 
The 4E-3 sample left untreated from the 4E3v4E3+CHX comparison, which denoted the 
mRNAs that were decreased in the presence of CHX, showed only one common motif family 
(Figure 19A).  This common motif, 4E-3 –CHX Specific Family 1, had a large uracil presence 
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with very little else.  The three mRNAs of note in this sample encoded for a verified type III 
restriction endonuclease subunit R, a putative nucleoside 2-deoxyribosyltransferase, and 
YLR356Qp, which is a putative uncharacterized mitochondrial protein (Figure 19B).   
 
There were a large number of possible hits for DNA motif identification, with a majority 
functioning as expression regulators or cell cycle regulators.  Of note are: REL Class motif at a 
divergence of 0.8, which regulates transcription factors; bZIP CEPB at a divergence of 0.799, 
which assists in regulation/promotion of expression; homeo box at a divergence of 0.73, which 
encodes for transcription factors that turn on other genes; MADS box at a divergence of 0.518, 
which assists in cell proliferation and is common to eukaryotes; cEBP at a divergence of 0.428, 
which assists in regulation/promotion of expression; TRP MYB at a divergence of 0.337, which 
assists with secondary metabolism; and HMG at a divergence of 0.287, which, with the binding 
of HMG proteins, affects the formation and function of transcription complexes (Table S4) 
[59][66-71]. 
 
The 4E-3 sample treated with Tet in the 4E3v4E3+Tet comparison, which denoted the 
mRNAs increased in the presence of Tet, showed no shared 3' UTR motifs in their mRNA.  This 
is due to the fact that most of the overrepresented mRNA lacked 3' UTRs larger than one 
nucleotide, which showed no indication of being conserved. 
 
The 4E-3 sample left untreated in the 4E3v4E3+Tet comparison, which denoted the 
mRNAs decreased in the presence of Tet, showed only one common motif family that was rich 
in alternating uracils and guanines (Figure 20A).  A location pattern did not specifically exist for 
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the mRNAs found to share the common motif, 4E-3 –Tet Specific Family 1, however there was a 
general trend for the motif to be located towards the beginning or the middle of the 3’ UTR 
(Figure 20B).  The key mRNAs decreased in the presence of Tet with this shared motif encode 
for mitochondrial, general gene expression, and cell cycle regulating proteins, such as a putative 
DNA-binding helix-turn-helix protein and a putative mitochondrial conserved eukaryotic protein 
(Figure 20B).   
 
Figure 20. Motifs specific for mRNA overrepresented in 4E-3 in the presence of Tet.  
 
(A) Graphical representation of mRNA motif nucleotide composition for mRNAs overrepresented in the anti-4E-3 
Ab pull down treated with tetracycline (Tet) in comparison to the anti-4E-3 Ab pull down. (B) List of mRNAs 
pulled down with their function, gene identifier, name, and whether they are experimentally Verified or Putative. 
 
There were a few possible DNA motif identities of note, such as: Mad box at a 
divergence of 0.858, which binds MADS transcription factors and plays a role in cell 
proliferation; bHLH at a divergence of 0.821, which allows dimerization, DNA binding, and 
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assists in the binding of transcription factors; TRP MYB at a divergence of 0.537, which is 
responsible for secondary metabolism; and HMG at a divergence of 0.518, which, with the 
binding of HMG proteins, affects the formation and transcription complexes (Table S5) 
[56][57][71][72]. 
4.7 SECONDARY STRUCTURE ANALYSIS FOR MOTIF LOCATION 
The 3' UTRs of groups of mRNAs exhibiting conserved motifs were analyzed using the 
RNAfold web server through the Vienna RNA Websuite to determine possible shared structural 
elements.  In general, each secondary structure contained an abundance of hair-pin loops and 
pseudo-knots.  Provided alongside the secondary structures were the percent frequency, which is 
the likelihood that one structure will exist at 37°C in comparison to the overall structure.  For 
each secondary structure analyzed, the percent frequency was zero or close to zero, meaning that 
the structure is highly unlikely to exist as a whole, however the 3’ UTR may form individual 
microstructures.  Also provided was a color scale for each secondary structure, with red 
representing the highest probability that a nucleotide is in the right structure, and purple 
representing the lowest probability. 
 
The first set of 3' UTRs analyzed were the TbeIF4E-5 (4E-5) specific mRNAs from the 
TbeIF4E-5 pulldown using the 4E-5 antibody (4E-5 ab) comparison with the TbeIF4E-3 (4E-3) 
pulldown using the 4E-3 antibody (4E-3 ab) (4E5v4E3).   A majority of the secondary structures 
were comprised of stem-loops based around a central loop, with a higher base-pair probability 
the further the nucleotides were from the general center of the structure, denoted by the yellow to 
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red colors.  The shared motifs had a heavy presence on the protruding stem-loops, with a total of 
99.6% existing on bulges and loops, with the starting nucleotide in the motif beginning on the 
double-helix stem, in most cases, while terminating at or near the end of a single-strand bulge 
(Figure 21, S1-11).  There did appear to be subsets of mRNA 3' UTRs in the 4E-5 sample, such 
as Tb927.7.4680 and Tb927.10.150, which share similar overall design (Fig. 21 D & H, S4 & 8).   
 
 
Figure 21. 4E-5 specific 3’ UTR secondary structure. 
 
(A-K) Visual representation of 3’ UTRs for mRNA sharing the common motif in the 4E-5 specific untreated sample.  
Each 3’ UTR structure is depicted in the minimum free energy configuration.  Black bars represent motif location, in 
each case extending from 3’-5’.  The first and last nucleotides are labeled for each structure. (L) Color guide 
representing the base-pair probability, where purple is the least likely and red is the most likely a nucleotide is in the 
proper place. The percent of motifs existing on bulges/loops is depicted in the upper right corner of each panel. 
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Figure 22. 4E-3 specific 3’ UTR secondary structure.  
 
(A-D) Visual representation of 3’ UTRs for mRNA sharing the common motif in the 4E-3 specific untreated sample.  
Each 3’ UTR structure is depicted in the minimum free energy configuration.  Black bars represent motif location, in 
each case extending from 3’-5’.  The first and last nucleotides are labeled for each structure. (E) Color guide 
representing the base-pair probability, where purple is the least likely and red is the most likely a nucleotide is in the 
proper place. The percent of motifs existing on bulges/loops is depicted in the upper right corner of each panel. 
 
The mRNA sharing a common motif from the 4E-3 sample in the 4E5v4E3 comparison 
have a general overall structure comprised of numerous bulges and pseudo-knots, with the 
highest base-pair probability existing primarily in the stems (Figure 22, S12-15).  The 3' UTRs 
of the mRNAs encoded by Tb927.2.900, Tb927.2.1250 and Tb927.4.120 shared the closest 
similarities, with all seven of the motif families being represented in generally the same 
locations, with a total of 97.7% of all motifs existing on bulges and loops (Figure 22 A-B & D).  
A majority of the motif families existed on the stem-loop structures projecting from pseudo-
knots, with the shared motifs consisting of one or more bulges.  The 3' UTR encoded by 
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Tb927.7.5910 is the only outlier, having only the Family 6 motif represented, however the 
structure remains similar (Figure 22 C). 
 
Figure 23. 4E-3+CHX Increase specific 3’ UTR secondary structure.  
 
(A-D) Visual representation of 3’ UTRs for mRNA sharing the common motif in the 4E-3 specific CHX treated 
sample.  Each 3’ UTR structure is depicted in the minimum free energy configuration.  Black bars represent motif 
location, in each case extending from 3’-5’.  The first and last nucleotides are labeled for each structure. (D) Color 
guide representing the base-pair probability, where purple is the least likely and red is the most likely a nucleotide is 
in the proper place. The percent of motifs existing on bulges/loops is depicted in the upper right corner of each 
panel. 
 
The sample comparison between 4E-3 untreated and 4E-3 treated with cycloheximide 
(CHX)(4E-3+CHX) was analyzed individually, with the 4E-3 untreated sample representing a 
decrease in mRNA and the 4E-3+CHX sample representing an increase in mRNA 
(4E3v4E3+CHX) (Figure 23, S16-19, 24, S20-28).  The 4E-3+CHX sample mRNAs shared few 
commonalities between each other, but still contained the pseudo-knots and stem-loop structures, 
with a total of 76.5% existing on bulges and loops (Figure 23, S16-19).  The base-pair stability 
lacked a shared theme, being most stable on the stems, loops and bulges.  The shared 3' UTR 
motifs consisted of these loops and bulges, extending on to double helical stem structures.   
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The structure of the 3' UTRs in the 4E-3 mRNA that were left untreated in the 
4E3v4E3+CHX comparison exhibit a wide range of complexity with few overall structural 
similarities, containing pseudo-knots and stem-loops.  The highest base-pair probabilities existed 
primarily on the stem structures, while 73.4% of the common motif is comprised mainly of loops 
and bulges (Figure 24, S20-28).   
 
 
Figure 24. 4E-3+CHX Decrease specific 3’ UTR secondary structure.  
 
(A-I) Visual representation of 3’ UTRs for mRNA sharing the common motif in the 4E-3 specific CHX untreated 
sample.  Each 3’ UTR structure is depicted in the minimum free energy configuration.  Black bars represent motif 
location, in each case extending from 3’-5’.  The first and last nucleotides are labeled for each structure. (J) Color 
guide representing the base-pair probability, where purple is the least likely and red is the most likely a nucleotide is 
in the proper place. The percent of motifs existing on bulges/loops is depicted in the upper right corner of each 
panel. 
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Due to the lack of shared motifs amongst the tetracycline (TET) induced 4E-3 sample in 
comparison to the 4E-3 untreated (4E3v4E3+TET), the 4E-3 untreated sample had the only 
mRNAs available for structural analysis (Figure 25, S29-37).  The 3' UTR secondary structures 
shared complexity, exhibiting pseudo-knots, stems, bulges and loops.  The main bulk of stem-
loop structures were off-shoots of pseudo-knot structures, while also maintaining the highest 
base-pair probabilities.  99.3% of the shared 3' UTR motifs primarily consisted of loops and 
bulges, extending on to stem structures.  In two mRNA 3' UTRs, Tb927.5.3740 and 
Tb927.7.5900, the shared motifs consisted of pseudo-knot structures (Figure 25 C-D, S29-37). 
 
 
 
Figure 25. 4E-3+Tet Decrease specific 3’ UTR secondary structure.  
 
(A-D) Visual representation of 3’ UTRs for mRNA sharing the common motif in the 4E-3 specific Tet untreated 
sample.  Each 3’ UTR structure is depicted in the minimum free energy configuration.  Black bars represent motif 
location, in each case extending from 3’-5’.  The first and last nucleotides are labeled for each structure. (D) Color 
guide representing the base-pair probability, where purple is the least likely and red is the most likely a nucleotide is 
in the proper place. The percent of motifs existing on bulges/loops is depicted in the upper right corner of each 
panel. 
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5.0  DISCUSSION 
The immunofluorescence results from the 4E-3p experiments show a general localization in the 
cytoplasm, while the 4E-5p shows co-localization foci/speckles with the mitochondria.  This 
latter observation is consistent with the finding that 4E-5p is part of the mitochondrial proteome 
and is unprecedented as the 4E proteins in other eukaryotes are localized in the cytoplasm and 
the nucleus, but not mitochondria.  This has profound implication on the evolution of 4Ep 
function since mitochondria are presumed to be prokaryotic in origin. 
 
Through MS analysis, the co-IP experiments were confirmed to be specific in their pull 
down of 4E-3p.  The identities of the associated proteins suggest 4E-3p association with the 
translation machinery, particularly the 4F complex, metabolic enzymes (potential feedback 
regulators of their own translation), and proteins with no known homology.  The specific pull 
down of 4G-4 and 4A1 by 4E-3 Ab coincide with previous experiments in the procyclic forms 
showing direct binding of 4E-3 with 4G-4 and 4A1 [1], and with other studies in other 
eukaryotes [73].  These results support the role of 4E-3p in translation and suggest a potential 
role in the regulation of the expression of metabolic enzymes, as well as association with unique 
proteins to perform still undetermined function(s).    
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The pulldown of the 4E-5p in the sample treated with the 4E-5 Ab verified the specificity 
of the 4E-5 Ab.  While there were no exceptional proteins specific to the 4E-5 sample, the shared 
translational proteins between the 4E-3 pulldown and 4E-5 pulldown support that 4E-5p is 
associated with translational machinery, however there was no evidence that 4E-5p interacts with 
the 4F complex. 
 
The RNAseq analysis and the caGEDA comparison indicated the association of multiple 
mRNAs unique to 4E-3p and 4E-5p.  The RNAseq analysis of the 4E-5p depicted a number of 
putative general gene expression mRNAs, such as the putative DNA polymerase, putative RNA 
directed DNA polymerase and the putative bifunctional DNA primase/polymerase.  The proteins 
encoded by these mRNAs either assist in or directly perform transcription, leading to a 
possibility that 4E-5p acts during the S-phase of cytokinesis.  Furthermore, the pull down of 
mRNAs encoding for a kinesin-like protein fragment support this assertion, as the putative 
kinesin-like proteins are important for cytokinesis [74][75].  There was also a pull down of 
mRNAs encoding for a putative S-phase kinase-associated protein 1, also a key component for 
cytokinesis [76].  The presence of a verified bloodstream stage alaninerich protein BARP, which 
is present in large numbers in the blood form stage, shows a possible association of 4E-5p with 
the life cycle and pathogenesis of trypanosomes [77].  Taken in concert with the 
immunofluorescence data and 4E-5p association with the membrane of the mitochondria, there is 
evidence that 4E-5p acts as a regulator of kinetoplast division during cytokinesis. 
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In comparison to the 4E-5p pull down in the RNAseq analysis, 4E-3p showed a large 
number of mRNAs encoding for proteins that assist with gene expression, RNA metabolism, and 
a host of other general mRNAs that assist in metabolism regulation and other general functions 
required by the cell.  Specifically, the mRNA encoding for 4A-1, a member of the 4F complex, 
was present.  The MS data showed the association of 4E-3p with 4A-1 and 4G-4, forming the 
possible 4F complex in trypanosomes, while these new data suggest a possible regulatory 
element possessed by 4E-3p in relation to the production of the 4F complex.  There was also a 
pull down of mRNAs encoding for a putative DNA directed RNA polymerase, which produces 
the primary transcript of DNA, suggesting that 4E-3p assists in transcription regulation.  The 
general gene expression mRNAs pulled down encoded for various proteins, such as a putative 
DNA repair protein C and a putative DNA mismatch repair protein, suggesting that 4E-3p assists 
in regulating DNA maintenance.  The presence of a large number of metabolic mRNAs 
coincides with the MS data to show a possible involvement of 4E-3p with metabolism.  Previous 
experiments have shown that with tetracycline induction of 4E-3 RNAi, the cells become 
deformed and shriveled, with slower growth, which could mean that 4E-3p also plays a role in 
metabolic regulation, and without 4E-3p the organism cannot produce proteins required to 
continue cell respiration.   
 
In the 4E3v4E3+CHX comparison, the 4E-3+CHX sample showed a large presence of 
mRNAs that encode for proteins that regulate metabolism and cell respiration.  Since CHX 
arrests translation and we assumed that the cells used in this sample were not stressed, then any 
mRNAs trapped during translation should be from normal cell function.  The large presence of 
metabolic mRNAs further suggested that 4E-3p plays a role in metabolism regulation.  Among 
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the mRNAs pulled down in the sample treated with CHX was a putative RNA helicase, showing 
further evidence for translation regulation as well, as the RNA helicase interacts with the 4F 
complex to unwind mRNA for translation.  The untreated 4E-3 sample in the 4E3v4E3+CHX 
comparison exhibits mRNAs decreased in the presence of CHX, however there should be no 
decrease of cellular functions or translational regulation.  As the mRNAs pulled down in this 
sample awere not outwardly important for cell cycle or cell growth, it can be assumed that these 
are general mRNAs not being translated at the moment of the CHX addition, and could possibly 
be transported from the nucleus or to storage vesicles as well.   
 
The comparison 4E3v4E3+Tet is quite important, as this revealed mRNAs decreased 
with the reduction of 4E-3p levels.  The mRNAs increased in expression when the RNAi cells 
were induced with tetracycline are largely metabolic in nature, with mRNAs encoding for 
putative RNA-editing complexes and a putative transposon Tn7 transposition protein being of 
any note in relation to gene expression.  In the untreated 4E-3 sample, showing a reduction of 
mRNA expression in the presence of Tet, there is a reduction of key transcription and translation 
factors, as well as cell cycle factors.  Of note is the reduction of 4E mRNAs, as well as mRNAs 
encoding for a putative DNA-binding helix-turn-helix, a putative DNA-directed RNA 
polymerase II subunit, and a putative dedicator of cytokinesis 11-like protein.  There was also a 
reduction of mRNAs encoding for putative metabolic proteins, as well as mRNAs encoding for 
putative mitochondrial proteins.  As 4E-3p associates with the cytoplasm, as shown with the 
immunofluorescence data, this suggests that 4E-3p is acting as a regulator of gene expression 
and at least some parts of the cell cycle. 
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The analysis of common motifs present in the 3’ UTRs of the 4E-5 sample from the 
4E5v4E3 comparison show a heavy concentration of uracils.  The mRNAs noted before in the 
4E-5 sample, those encoding for a verified bloodstream stage alaninerich protein BARP, a 
putative S-phase kinase-associated protein 1, and the general gene expression proteins, share this 
motif, suggesting that 4E-5p does act in cell cycle regulation.  Combined with the 
immunofluorescence data, showing an association with the mitochondrion of trypanosomes, 
there is strong evidence that 4E-5p assists in the kinetoplastic replication during the S-phase of 
trypanosoma cell growth. 
 
The analysis of common motifs present in the 3’ UTR of mRNAs targeted by 4E-3p 
shows a common trend amongst all of the sample comparisons with 4E-3p.  The evidence points 
to 4E-3p preferentially targeting mRNAs with uracil-guanine sequences in the 3’ UTR, shown in 
the sample comparisons 4E5v4E3 and 4E3v4E3+Tet.  Again, it is assumed that the addition of 
CHX to the 4E-3 antibody pull down does not change the specificity of 4E-3p, but just captures 
the translational machinery at a different time point than seen in the sample without CHX.  The 
addition of tetracycline causes a reduction in 4E-3p levels, also causing a reduction in the 
mRNAs 4E-3p preferably targets, as supported by the untreated 4E-3 pulldown in comparison to 
the tetracycline induced sample.  The 4E3v4E3+Tet comparison shows a common motif rich in 
uracils and guanines in the 4E-3 +Tet Decrease Sample, representing those mRNAs reduced in 
the presence of tetracycline, however the mRNAs overexpressed in the tetracycline induced 
sample had no common motif due to the 3' UTRs containing only one nucleotide on average.  
This shows the possibility that although 4E-3p regulates general gene expression and metabolism 
mRNAs exhibiting a common motif, while also interacting with general mRNAs.  The sample 
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comparison 4E3v4E3+CHX also has a large presence of uracils in the common motifs, with 
small amounts of other nucleotides. 
 
All of the sample specific mRNA 3’ UTR secondary structures show a significant 
tendency of the shared motif to exist on bulges and loops.  This supports the regulatory role of 
4E-5p and 4E-3p through direct or indirect interaction with the 3’ UTR of mRNAs, with the 
motifs differing between the 4E-3 and 4E-5 samples.  However, the 3’ UTR secondary structures 
are unstable as a whole, requiring further experiments to be performed to verify their importance 
for 4E-3p and 4E-5p interaction. 
 
While the immunofluorescence data show an association of 4E-5p with the 
mitochondrion, the RNAseq data do not show any association with mitochondrial mRNAs, nor 
do the MS data show any association with mitochondrial proteins.  However, the data instead 
suggests that 4E-5p acts as a cell cycle regulator and assists in either replication or transcription.  
Since there are no mRNAs associated with 4E-5p that directly encode for parts of glycolysis or 
the mitochondrial proteome, we propose that 4E-5p plays a role in kinetoplast replication during 
the S-phase of trypanosome division, which would be unprecedented for a 4E homolog 
associating with an organelle of possible prokaryotic origin [37]. 
 
The immunofluorescence data support the 4E-3p translational role in the cytoplasm, with 
the MS data further supporting 4E-3p being a bona fide unit in the TbeIF4F complex with the 
association of 4A-1 and 4G-4.  The RNAseq data provides evidence for 4E-3p’s role in 
regulating the same 4F complex that this homolog belongs to, while also regulating transcription 
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and parts of the metabolic cycle.  Since, 4E proteins in other eukaryotes act to transport mRNAs 
from the nucleus to the translation complex, or from the nucleus to storage vacuoles for later 
translation or degradation, it can be deduced that 4E-3p acts to recognize and transport specific 
mRNAs from the nucleus to the translation complex as well [20][54][78].   
 
Figure 26.  Parallel Regulon Model.   
 
1. The mass spectrometry data showed association of 4E-3p with bona fide parts of the eIF4F (4F) complex, which 
are required for translation initiation.  Although 4E-5p showed no association with a 4F complex, ribosomes 
responsible for translation were present, supporting the previous evidence that 4E-5p is a homolog of eIF4E.  2.  The 
RNAseq and caGEDA analysis showed unique mRNAs overrepresented in both the 4E-3 and 4E-5 antibody 
pulldowns.  The overrepresented mRNAs in 4E-3 encoded for putative and verified cell cycle regulating proteins, 
proteins that regulate metabolism and cell function, and proteins that regulate transcription and translation.  While 
the overrepresented mRNAs in 4E-r encoded for proteins of similar function, there were no shared pathways.  3.  
The findings show the possibility that 4E-3p and 4E-5p act on distinct regulons, or groups of mRNAs that share 
similar function, in order to regulate cell function and cell cycle. 
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Overall, the motif data suggest that 4E-3p and 4E-5p interact with unique yet functionally 
related mRNAs (Figure 26).  The immunofluorescence confirms the association of 4E-3p with 
the cytoplasm, with the MS data supporting 4E-3p associating with translational machinery.  The 
RNAseq data show 4E-3p association with a wide variety of mRNAs that encode for proteins 
that assist with a host of cell functions, with Trawler showing 4E-3p regulating mRNAs sharing 
common motifs in their 3’ UTR and possibly belonging to a regulon, a regulon being a 
functionally related group of mRNA regulated by a protein or proteins.  These mRNAs sharing 
the motifs encode for possible transcriptional proteins, translational proteins, and proteins that 
assist with metabolism and cell respiration.  This would mean 4E-3p works to not only control 
specific gene expression functions, but to also control general cell cycle and survival.  The 
immunofluorescence confirms 4E-5p association with the mitochondrion.  The MS data reveal 
no specific interaction of 4E-5p to the eIF4F complex, however the presence of ribosomes that 
assist in translation show the possibility of 4E-5p acting to regulate protein function while being 
associated with the mitochondrion, which would be unprecedented.  The RNAseq data show the 
possible association of 4E-5p with mRNAs that encode for cell cycle regulators and 
transcriptional proteins.  The Trawler analysis of these mRNAs show a common motif shared 
between these mRNAs, supporting the possibility that 4E-5p also acts upon its own regulons.  
This supports our Parallel Regulon Theory, with 4E-3p and 4E-5p interacting independently with 
functionally related mRNA that belong to separate pathways to regulate cell cycle and gene 
expression. 
 
 These data could be used to provide a foundation for the understanding of T. brucei’s 4E-
3p and 4E-5p, and act as a launching point for further studies in to the specific interactions of 
 75 
these proteins with translation machinery and mRNA.  The evidence of 4E-5p interacting with 
the mitochondrion is unprecedented, and should be further analyzed in other early protozoans, as 
well as the members of the TriTryps, to determine consistency.  The association of 4E-3p with 
the cytoplasm and translation machinery confirms previous studies pertaining to 4E-3p function 
and localization.  Effort can now be focused on confirming the identities of the 4E-3p protein 
interactors and associated mRNAs, as well as their specific function in cell cycle. 
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6.0  FUTURE DIRECTIONS 
The findings presented here represent only the tip of the iceberg.  While great effort was used to 
perform in silico analyses to make up for the lack of experimental evidence to confidently 
propose functions for 4E-3p and 4E-5p, further experimental evidence is required to extend the 
findings presented here. 
 
Further co-immunoprecipitation pulldowns with associated mass spectrometry of 4G-4 
and 4A-1 would provide solid evidence of 4E-3p’s association with the trypanosomal 4F 
complex, and to functionally validate anticipated 4E-3 and 4E-5 mRNA targets via qPCR of 
polysome-derived mRNAs with and without 4E-3 RNAi to determine their loss of translation 
recruitment during RNAi.  The association of 4E-5p with replication and cell cycle machinery, 
while also being directly associated to the mitochondria are unprecedented, and would require 
further evidence to fully support the evidence provided by us in these studies.   
 
Mass spectrometry focusing on 4E-5p and the associated complexes would assist in 
verifying the role of 4E-5p in translation, and confirm association with possible eIF4F subunits.  
Running the RNAseq experiments with comparisons between a 4E-5p pull down against a 
tetracycline induced 4E-5 RNAi pull down would show which mRNAs 4E-5 specifically targets, 
with a comparison with 4E-5 pull downs treated with cycloheximide to arrest translation would 
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show which mRNAs are being translated at that exact moment and whether 4E-5p acts to 
transport mRNAs.  While previous studies have shown that the protein we identified to be 4E-5 
is part of the mitochondrial proteome, there was little evidence of mRNAs that target the 
mitochondria.  However, the large amount of mRNAs encoding for hypothetical unknowns could 
provide polypeptides unique to trypanosomes, and may show a degree of importance.     
 
The motif data showed conserved motifs in the 3’ UTRs of mRNA overrepresented in 
both 4E-3p and 4E-5p.  An in silico meta-analysis of the entire T. brucei genome could provide 
information on how prevalent those motifs are.  While they maintained high z scores, there was 
no way to properly judge their prevalence.  Provided alongside these motifs were possible 
identities.  These identities are specific for only DNA motifs.  Since T. brucei is polycistronic, an 
effort should be made to determine whether these motifs in the mRNA are also present on the 
chromosomes, and whether they assist in proper cleavage of the pre-mRNA.  This could be 
performed using Trawler on individual genes in the genome, while also knocking out, through 
point mutations, the motif sequences in the chromosomes to determine whether the presence of 
the transcribed mRNA is decreased.  The importance of the secondary structure to 4E-3p or 4E-
5p interaction with the 3’ UTR of mRNA would require point mutations or deletions where the 
motif is located, and then analyzed for a decreased interaction or a decreased production of the 
encoded protein.   
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APPENDIX: SUPLEMENTAL FIGURES AND TABLES 
The motif results provided by Trawler included possible motif identities with their divergence, or 
percent relevance.  However, these identities are for motifs found on the DNA, and would not be 
critical to mRNA selection or function.  They were included here for informational purposes, and 
could possibly hint at the importance of the motif during the cleaving of the polycistronic pre-
mRNA (Tables S1-S5).  The rest of the figures show enlarged versions of the mRNA 3’ UTR 
secondary structures generated by the RNAfold webserver, through the Vienne RNA Websuite, 
to allow for a better understanding and analysis of motif location and overall structure (Figures 
S1-S37). 
 
Table S1. Motif name, divergence, and function for each 4E-5 specific family, organized by divergence.   
 
 
 
The first column lists the possible identity of the motif discovered by Trawler.  The second column shows the 
divergence, or percent relevance, of these identities.  The third column shows the possible function of the motif 
identity, discovered via literature searches. 
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Table S2. Motif name, divergence, and function for each 4E-3 specific family, organized by divergence.   
 
 
 
 
The first column lists the possible identity of the motif discovered by Trawler.  The second column shows the 
divergence, or percent relevance, of these identities.  The third column shows the possible function of the motif 
identity, discovered via literature searches. 
 
 
 
 
Table S3. Motif name, divergence, and function for each 4E-3+CHX Increase specific family, organized by 
divergence.   
 
 
 
 
The first column lists the possible identity of the motif discovered by Trawler.  The second column shows the 
divergence, or percent relevance, of these identities.  The third column shows the possible function of the motif 
identity, discovered via literature searches. 
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Table S4. Motif name, divergence, and function for each 4E-3-CHX Increase specific family, organized by 
divergence.   
 
 
 
 
The first column lists the possible identity of the motif discovered by Trawler.  The second column shows the 
divergence, or percent relevance, of these identities.  The third column shows the possible function of the motif 
identity, discovered via literature searches. 
 
 
 
 
Table S5. Motif name, divergence, and function for each 4E-3-Tet Increase specific family, organized by 
divergence.   
 
 
 
 
The first column lists the possible identity of the motif discovered by Trawler.  The second column shows the 
divergence, or percent relevance, of these identities.  The third column shows the possible function of the motif 
identity, discovered via literature searches. 
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Figure S1. Enlarged version of Figure 21A.   
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with 
red being the highest and purple being the lowest.  The gene identifier for the mRNA provided by the 
RNAseq has been included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S2. Enlarged version of Figure 21B.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S3. Enlarged version of Figure 21C.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S4. Enlarged version of Figure 21D.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities 
are represented, with red being the highest and purple being the lowest.  The gene 
identifier for the mRNA provided by the RNAseq has been included. Black bars 
represent the motif occurrence in the nucleotide sequences. 
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Figure S5. Enlarged version of Figure 21E.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S6. Enlarged version of Figure 21F.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities 
are represented, with red being the highest and purple being the lowest.  The gene 
identifier for the mRNA provided by the RNAseq has been included. Black bars 
represent the motif occurrence in the nucleotide sequences. 
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Figure S7. Enlarged version of Figure 21G.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S8. Enlarged version of Figure 21H.  
 
This is a model of the mRNA 3’ UTR secondary structure.  
Base pair probabilities are represented, with red being the 
highest and purple being the lowest.  The gene identifier 
for the mRNA provided by the RNAseq has been included. 
Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S9. Enlarged version of Figure 21I.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair 
probabilities are represented, with red being the highest and purple 
being the lowest.  The gene identifier for the mRNA provided by the 
RNAseq has been included. Black bars represent the motif occurrence 
in the nucleotide sequences. 
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Figure S10. Enlarged version of Figure 21J.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, 
with red being the highest and purple being the lowest.  The gene identifier for the mRNA provided 
by the RNAseq has been included. Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S11. Enlarged version of Figure 21K.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair 
probabilities are represented, with red being the highest and purple being the 
lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S12. Enlarged version of Figure 22A.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities 
are represented, with red being the highest and purple being the lowest.  The gene 
identifier for the mRNA provided by the RNAseq has been included. Black bars 
represent the motif occurrence in the nucleotide sequences. 
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Figure S13. Enlarged version of Figure 22B.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are 
represented, with red being the highest and purple being the lowest.  The gene identifier for 
the mRNA provided by the RNAseq has been included. Black bars represent the motif 
occurrence in the nucleotide sequences. 
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Figure S14. Enlarged version of Figure 22C.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, 
with red being the highest and purple being the lowest.  The gene identifier for the mRNA provided 
by the RNAseq has been included. Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S15. Enlarged version of Figure 22D.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S16. Enlarged version of Figure 23A.  
 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair 
probabilities are represented, with red being the highest and purple being the 
lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S17.  Enlarged version of Figure 23B. 
This is a model of the mRNA 3’ UTR secondary 
structure.  Base pair probabilities are 
represented, with red being the highest and 
purple being the lowest.  The gene identifier for 
the mRNA provided by the RNAseq has been 
included. Black bars represent the motif 
occurrence in the nucleotide sequences. 
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Figure 18. Enlarged version of Figure 23C. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are 
represented, with red being the highest and purple being the lowest.  The gene identifier for 
the mRNA provided by the RNAseq has been included. Black bars represent the motif 
occurrence in the nucleotide sequences. 
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Figure S19. Enlarged version of Figure 23D. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are 
represented, with red being the highest and purple being the lowest.  The gene 
identifier for the mRNA provided by the RNAseq has been included. Black bars 
represent the motif occurrence in the nucleotide sequences. 
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Figure S20. Enlarged version of Figure 24A. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S21. Enlarged version of Figure 24B. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S22. Enlarged version of Figure 24C. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair 
probabilities are represented, with red being the highest and purple being the 
lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S23. Enlarged version of Figure 24D. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are 
represented, with red being the highest and purple being the lowest.  The gene 
identifier for the mRNA provided by the RNAseq has been included. Black bars 
represent the motif occurrence in the nucleotide sequences. 
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Figure S24. Enlarged version of Figure 24E. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S25. Enlarged version of Figure 24F. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, 
with red being the highest and purple being the lowest.  The gene identifier for the mRNA provided 
by the RNAseq has been included. Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S26. Enlarged version of Figure 24G. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S27.  Enlarged version of Figure 24H. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair 
probabilities are represented, with red being the highest and purple being 
the lowest.  The gene identifier for the mRNA provided by the RNAseq has 
been included. Black bars represent the motif occurrence in the nucleotide 
sequences. 
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Figure S28. Enlarged version of Figure 24I. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S29. Enlarged version of Figure 25A. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S30. Enlarged version of Figure 25B. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
111 
Figure S31. Enlarged version of Figure 25C. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S32. Enlarged version of Figure 
25D.  
This is a model of the mRNA 3’ UTR 
secondary structure.  Base pair 
probabilities are represented, with red 
being the highest and purple being the 
lowest.  The gene identifier for the mRNA 
provided by the RNAseq has been 
included. Black bars represent the motif 
occurrence in the nucleotide sequences. 
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Figure S33. Enlarged version of Figure 25E. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S34. Enlarged version of Figure 25F. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S35. Enlarged version of Figure 25G. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are 
represented, with red being the highest and purple being the lowest.  The gene identifier for the 
mRNA provided by the RNAseq has been included. Black bars represent the motif occurrence 
in the nucleotide sequences. 
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Figure S36. Enlarged version of Figure 25H. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red 
being the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq 
has been included. Black bars represent the motif occurrence in the nucleotide sequences. 
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Figure S37. Enlarged version of Figure 25I. 
This is a model of the mRNA 3’ UTR secondary structure.  Base pair probabilities are represented, with red being 
the highest and purple being the lowest.  The gene identifier for the mRNA provided by the RNAseq has been 
included. Black bars represent the motif occurrence in the nucleotide sequences. 
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